Text · Amendment list
Modernised rules for patients’ rights in cross-border healthcare
Document SANT-AM-792014 · 2025/2206(INL)
- Kind
- Amendment list SANT-AM-792014
- Date
- 11 September 2026
- Committee
- Committee on Public Health
- Dossier
- 2025-2206
More facts (2)
- Formats
- Official page PDF Word
- Reference
- 2025/2206(INL)
Text
The text as parsed from the official Word file. Every paragraph has a link (¶) and can be saved to a project as a passage.
Jump to an amendment (341)
- Amendment 1
- Amendment 2
- Amendment 3
- Amendment 4
- Amendment 5
- Amendment 6
- Amendment 7
- Amendment 8
- Amendment 9
- Amendment 10
- Amendment 11
- Amendment 12
- Amendment 13
- Amendment 14
- Amendment 15
- Amendment 16
- Amendment 17
- Amendment 18
- Amendment 19
- Amendment 20
- Amendment 21
- Amendment 22
- Amendment 23
- Amendment 24
- Amendment 25
- Amendment 26
- Amendment 27
- Amendment 28
- Amendment 29
- Amendment 30
- Amendment 31
- Amendment 32
- Amendment 33
- Amendment 34
- Amendment 35
- Amendment 36
- Amendment 37
- Amendment 38
- Amendment 39
- Amendment 40
- Amendment 41
- Amendment 42
- Amendment 43
- Amendment 44
- Amendment 45
- Amendment 46
- Amendment 47
- Amendment 48
- Amendment 49
- Amendment 50
- Amendment 51
- Amendment 52
- Amendment 53
- Amendment 54
- Amendment 55
- Amendment 56
- Amendment 57
- Amendment 58
- Amendment 59
- Amendment 60
- Amendment 61
- Amendment 62
- Amendment 63
- Amendment 64
- Amendment 65
- Amendment 66
- Amendment 67
- Amendment 68
- Amendment 69
- Amendment 70
- Amendment 71
- Amendment 72
- Amendment 73
- Amendment 74
- Amendment 75
- Amendment 76
- Amendment 77
- Amendment 78
- Amendment 79
- Amendment 80
- Amendment 81
- Amendment 82
- Amendment 83
- Amendment 84
- Amendment 85
- Amendment 86
- Amendment 87
- Amendment 88
- Amendment 89
- Amendment 90
- Amendment 91
- Amendment 92
- Amendment 93
- Amendment 94
- Amendment 95
- Amendment 96
- Amendment 97
- Amendment 98
- Amendment 99
- Amendment 100
- Amendment 101
- Amendment 102
- Amendment 103
- Amendment 104
- Amendment 105
- Amendment 106
- Amendment 107
- Amendment 108
- Amendment 109
- Amendment 110
- Amendment 111
- Amendment 112
- Amendment 113
- Amendment 114
- Amendment 115
- Amendment 116
- Amendment 117
- Amendment 118
- Amendment 119
- Amendment 120
- Amendment 121
- Amendment 122
- Amendment 123
- Amendment 124
- Amendment 125
- Amendment 126
- Amendment 127
- Amendment 128
- Amendment 129
- Amendment 130
- Amendment 131
- Amendment 132
- Amendment 133
- Amendment 134
- Amendment 135
- Amendment 136
- Amendment 137
- Amendment 138
- Amendment 139
- Amendment 140
- Amendment 141
- Amendment 142
- Amendment 143
- Amendment 144
- Amendment 145
- Amendment 146
- Amendment 147
- Amendment 148
- Amendment 149
- Amendment 150
- Amendment 151
- Amendment 152
- Amendment 153
- Amendment 154
- Amendment 155
- Amendment 156
- Amendment 157
- Amendment 158
- Amendment 159
- Amendment 160
- Amendment 161
- Amendment 162
- Amendment 163
- Amendment 164
- Amendment 165
- Amendment 166
- Amendment 167
- Amendment 168
- Amendment 169
- Amendment 170
- Amendment 171
- Amendment 172
- Amendment 173
- Amendment 174
- Amendment 175
- Amendment 176
- Amendment 177
- Amendment 178
- Amendment 179
- Amendment 180
- Amendment 181
- Amendment 182
- Amendment 183
- Amendment 184
- Amendment 185
- Amendment 186
- Amendment 187
- Amendment 188
- Amendment 189
- Amendment 190
- Amendment 191
- Amendment 192
- Amendment 193
- Amendment 194
- Amendment 195
- Amendment 196
- Amendment 197
- Amendment 198
- Amendment 199
- Amendment 200
- Amendment 201
- Amendment 202
- Amendment 203
- Amendment 204
- Amendment 205
- Amendment 206
- Amendment 207
- Amendment 208
- Amendment 209
- Amendment 210
- Amendment 211
- Amendment 212
- Amendment 213
- Amendment 214
- Amendment 215
- Amendment 216
- Amendment 217
- Amendment 218
- Amendment 219
- Amendment 220
- Amendment 221
- Amendment 222
- Amendment 223
- Amendment 224
- Amendment 225
- Amendment 226
- Amendment 227
- Amendment 228
- Amendment 229
- Amendment 230
- Amendment 231
- Amendment 232
- Amendment 233
- Amendment 234
- Amendment 235
- Amendment 236
- Amendment 237
- Amendment 238
- Amendment 239
- Amendment 240
- Amendment 241
- Amendment 242
- Amendment 243
- Amendment 244
- Amendment 245
- Amendment 246
- Amendment 247
- Amendment 248
- Amendment 249
- Amendment 250
- Amendment 251
- Amendment 252
- Amendment 253
- Amendment 254
- Amendment 255
- Amendment 256
- Amendment 257
- Amendment 258
- Amendment 259
- Amendment 260
- Amendment 261
- Amendment 262
- Amendment 263
- Amendment 264
- Amendment 265
- Amendment 266
- Amendment 267
- Amendment 268
- Amendment 269
- Amendment 270
- Amendment 271
- Amendment 272
- Amendment 273
- Amendment 274
- Amendment 275
- Amendment 276
- Amendment 277
- Amendment 278
- Amendment 279
- Amendment 280
- Amendment 281
- Amendment 282
- Amendment 283
- Amendment 284
- Amendment 285
- Amendment 286
- Amendment 287
- Amendment 288
- Amendment 289
- Amendment 290
- Amendment 291
- Amendment 292
- Amendment 293
- Amendment 294
- Amendment 295
- Amendment 296
- Amendment 297
- Amendment 298
- Amendment 299
- Amendment 300
- Amendment 301
- Amendment 302
- Amendment 303
- Amendment 304
- Amendment 305
- Amendment 306
- Amendment 307
- Amendment 308
- Amendment 309
- Amendment 310
- Amendment 311
- Amendment 312
- Amendment 313
- Amendment 314
- Amendment 315
- Amendment 316
- Amendment 317
- Amendment 318
- Amendment 319
- Amendment 320
- Amendment 321
- Amendment 322
- Amendment 323
- Amendment 324
- Amendment 325
- Amendment 326
- Amendment 327
- Amendment 328
- Amendment 329
- Amendment 330
- Amendment 331
- Amendment 332
- Amendment 333
- Amendment 334
- Amendment 335
- Amendment 336
- Amendment 337
- Amendment 338
- Amendment 339
- Amendment 340
- Amendment 341
| Motion for a resolution | Amendment |
|---|---|
| – having regard to Article 174 of the Treaty of the Functioning of the European Union, and especially the Union's obligation to pay particular attention to regions which suffer from severe and permanent natural or demographic handicaps, including island, mountain and cross-border regions and regions with low population density, |
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the European Parliament’s forthcoming INL report on rare diseases, |
| Motion for a resolution | Amendment |
|---|---|
| – having regard to Regulation (EU) 2025/925 of the European Parliament and of the Council on identifying and resolving legal and administrative cross-border obstacles (BRIDGEforEU), |
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Commission communication of 3 February 2021 entitled ‘Europe’s Beating Cancer Plan’ (COM(2021)0044) and the Commission Communication of 29 September 2021 on European Missions which sets out the EU Cancer Mission (COM(2021)609), |
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Commission communication of 6 May 2026 entitled ‘The EU Anti-Poverty Strategy: addressing and preventing poverty from childhood to old age’ (COM(2026)538), |
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Commission communication of 6 May 2026 entitled ‘The EU Anti-Poverty Strategy: addressing and preventing poverty from childhood to old age’ (COM(2026)538), |
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the report of the Committee on Public Health with recommendations to the Commission on an EU Rare Disease Action Plan (2025/2130(INL)), |
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Commission communication of 6 May 2026 entitled ‘The EU Anti-Poverty Strategy: addressing and preventing poverty from childhood to old age’ (COM(2026)538), |
| Motion for a resolution | Amendment |
|---|---|
| A. whereas health is a fundamental human right, not a privilege; | A. whereas health is a fundamental human right, not a privilege; whereas Article 168(1) of the Treaty on the Functioning of the European Union (TFEU) provides that a high level of human health protection is ensured in the definition and implementation of all Union policies, and whereas Article 35 of the Charter of Fundamental Rights recognises the right to access preventive healthcare and to benefit from medical treatment; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak
| Motion for a resolution | Amendment |
|---|---|
| A. whereas health is a fundamental human right, not a privilege; | A. whereas, according to Article 35 of the European Charter of Fundamental Rights, access to preventive healthcare and the benefit of medical treatment is a fundamental human right, not a privilege; |
| Motion for a resolution | Amendment |
|---|---|
| A. whereas health is a fundamental human right, not a privilege; | A. whereas health is a fundamental human right, not a privilege, and healthcare should remain a public service; |
| Motion for a resolution | Amendment |
|---|---|
| Aa. whereas approximately 95 % of rare diseases lack an authorised therapeutic option and, where treatments exist, access across Member States remains uneven, resulting in disparities in patient outcomes; whereas a significant proportion of patients with suspected rare diseases remain without a confirmed diagnosis; whereas addressing the needs of undiagnosed patients requires improved access to specialised expertise, advanced diagnostic technologies and cross-border collaboration across the Union; |
| Motion for a resolution | Amendment |
|---|---|
| Aa. whereas Directive 2011/24/EU constituted a major development for patient’s rights, being one of the pieces of legislation that codified rules on access to healthcare and levering the rights of European patients to effective treatment across the Union; |
| Motion for a resolution | Amendment |
|---|---|
| Aa. whereas, in the spirit of the European Health Union, common European actions are increasingly needed to respond to current and future healthcare challenges and emergencies, by facilitating and encouraging cross-border healthcare; |
| Motion for a resolution | Amendment |
|---|---|
| Aa. whereas health and access to quality care are the foundation of individual freedom, empowering every citizen, regardless of their health status, to exercise their rights, make free choices, and participate fully in society; |
| Motion for a resolution | Amendment |
|---|---|
| Ab. whereas cross-border healthcare has strong potential to improve quality of healthcare received by patients and reduce care deficit and treatment bottlenecks present in numerous Member States, which is why its usage should be substantially increased; |
| Motion for a resolution | Amendment |
|---|---|
| Ab. whereas a citizen’s place of residence or postal code must never limit their personal choices or determine the quality of care, and equitable access to healthcare must be guaranteed across all regions of the Union; |
| Motion for a resolution | Amendment |
|---|---|
| B. whereas, on the basis of the conclusions of the European Court of Auditors, Directive 2011/24/EU, has failed to eliminate structural barriers to access, including advance payment requirements, opaque prior authorisation procedures, inadequate reimbursement frameworks and the fragmented information; | B. whereas, on the basis of the conclusions of the European Court of Auditors, Directive 2011/24/EU has failed to encourage utilization of cross-border healthcare and to eliminate structural and administrative barriers to access to cross-border healthcare, including advance payment requirements, opaque prior authorisation procedures, inadequate interoperable reimbursement frameworks and fragmented information; |
| Motion for a resolution | Amendment |
|---|---|
| B. whereas, on the basis of the conclusions of the European Court of Auditors, Directive 2011/24/EU, has failed to eliminate structural barriers to access, including advance payment requirements, opaque prior authorisation procedures, inadequate reimbursement frameworks and the fragmented information; | B. whereas, on the basis of the conclusions of the European Court of Auditors, Directive 2011/24/EU had a limited concrete impact on patients, has failed to eliminate structural barriers to access, including advance payment requirements, opaque prior authorisation procedures, inadequate reimbursement frameworks and the fragmented information; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| B. whereas, on the basis of the conclusions of the European Court of Auditors, Directive 2011/24/EU, has failed to eliminate structural barriers to access, including advance payment requirements, opaque prior authorisation procedures, inadequate reimbursement frameworks and the fragmented information; | B. whereas, on the basis of the conclusions of the European Court of Auditors, Directive 2011/24/EU, has failed to eliminate structural barriers to access, including advance payment requirements, opaque prior authorisation procedures, inadequate reimbursement frameworks, disproportionate administrative burden and the fragmented information; |
| Motion for a resolution | Amendment |
|---|---|
| Ba. whereas, according to the court of Auditors, the number of citizens claiming reimbursement for medical care received abroad under the Directive is fewer than 0.05 % of EU citizens, which correspond to approximately 200 000 claims a year, and lower than the number of citizens making use of the Regulation on the coordination of social security systems which amount to approximately 2 million claims a year for unplanned treatments abroad. Whereas, according to the court of auditors, a 2015 Eurobarometer survey reported that fewer than 20 % of citizens were aware of their rights regarding cross-border healthcare; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| Ba. whereas access to cross-border healthcare under Directive 2011/24/EU remains, in practice, subject to significant socio-economic hurdles that fall disproportionately on patients with limited financial means, mainly because of existing upfront payment obligations; whereas vulnerable patients, including those with chronic or rare diseases, persons with disabilities and patients with less financial means are particularly exposed to these hurdles; |
| Motion for a resolution | Amendment |
|---|---|
| Ba. whereas patients requiring innovative therapies may be disproportionately affected by the complexity of the Union framework for cross-border healthcare; whereas insufficient information, high upfront costs, uncertainty regarding reimbursement and complex administrative procedures may create additional barriers for those patients and increase the burden associated with their condition; |
| Motion for a resolution | Amendment |
|---|---|
| Ba. whereas the monitoring and evaluation frameworks under Directive 2011/24/EU and the Social Security Regulations are based on non-harmonised indicators for assessing cross-border access to healthcare services, thereby measuring the same underlying phenomenon in inconsistent ways; |
| Motion for a resolution | Amendment |
|---|---|
| Ba. whereas major inequalities in access to healthcare persist across the European Union, particularly affecting low-income persons, persons with disabilities, older persons, migrants and residents of rural or remote regions; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| Bb. whereas the coexistence of two legal frameworks covering cross-border healthcare has resulted in a complex system which lacks transparency; whereas patients are frequently not adequately informed as to which of the two frameworks applies to their situation, nor as to the fact that they may be entitled to choose the framework most favourable to them; whereas this lack of clarity places an undue burden on patients to navigate two parallel and imperfectly coordinated systems, and risks undermining the objective of both instruments to facilitate effective access to cross-border healthcare; |
| Motion for a resolution | Amendment |
|---|---|
| Bb. whereas socioeconomic inequalities are systematically reproduced within the current cross-border healthcare framework; patients from lower-income backgrounds are disproportionately excluded from exercising cross-border care rights due to the requirement to pay full treatment costs upfront before reimbursement, a barrier that has no objective justification and that actively discriminates against the poorest and most vulnerable patients in the Union; |
| Motion for a resolution | Amendment |
|---|---|
| Bb. whereas according to the 2022 Commission evaluation of Directive 2011/24/EU, the Directive’s potential for improving access to cross-border healthcare continues to be hampered by some issues, including, in particular, the low level of awareness over patients’ rights to cross-border healthcare, inadequate patient information, disproportionate administrative burdens, and uncertainty over healthcare costs abroad and reimbursement; |
| Motion for a resolution | Amendment |
|---|---|
| Bb. whereas the monitoring and evaluation frameworks underpinning both Directive 2011/24/EU and the Social Security Regulations fail to adequately assess patients’ and healthcare professionals’ awareness of the legal rights and administrative pathways available to access cross-border healthcare, as well as the non-clinical costs borne by patients and their families and other relevant dimensions of access; |
| Motion for a resolution | Amendment |
|---|---|
| Bc. whereas, according to the European Commission 2025 trend report on Member State data on cross-border patient healthcare, 15 to 20% of requests for prior authorisation or reimbursement for cross-border treatment are refused by national health authorities; whereas it is often unclear what criteria Member States apply and if criteria are applied consistently across Member States; |
| Motion for a resolution | Amendment |
|---|---|
| C. whereas cross-border healthcare must complement strong, universal and publicly funded national healthcare systems; | C. whereas cross-border healthcare must be simple and easily accessible and complement strong, universal and publicly funded national healthcare systems; |
| Motion for a resolution | Amendment |
|---|---|
| Ca. whereas the aforementioned Social Security Regulations (Regulation (EC) No 883/2004 on the coordination of social security systems and Regulation (EC) No 987/2009) continue to provide a possible legal route for accessing healthcare abroad, the coexistence of two parallel legal routes to access cross-border healthcare has increased bureaucratic complexity and Directive 2011/24/EU has not provided people living with a rare and complex diseases with a meaningful alternative to travel abroad for care; |
| Motion for a resolution | Amendment |
|---|---|
| Ca. whereas patients continue to face administrative barriers, excessive waiting times and unequal reimbursement procedures when accessing healthcare in another Member State; |
| Motion for a resolution | Amendment |
|---|---|
| Ca. whereas enhanced cooperation between Member States is necessary to ensure access to safe and high-quality cross-border healthcare; |
| Motion for a resolution | Amendment |
|---|---|
| Cb. whereas a single regulatory instrument would guarantee uniform patient rights and avoid administrative delays that have direct and often irreversible clinical and life-long consequences for the patients; |
| Motion for a resolution | Amendment |
|---|---|
| D. whereas the European Reference Networks (ERNs) sustainability is endangered by precarious funding, inadequate legal recognition and uneven participation across Member States, and ERNs must be significantly strengthened and placed on a permanent, adequately resourced footing; | D. whereas the European Reference Networks (ERNs) sustainability is endangered by precarious funding, including the lack of dedicated reimbursement for healthcare professionals participating in cross-border virtual consultation panels, inadequate legal recognition and uneven participation across Member States, and ERNs must be significantly strengthened and placed on a permanent, adequately resourced footing; |
| Motion for a resolution | Amendment |
|---|---|
| D. whereas the European Reference Networks (ERNs) sustainability is endangered by precarious funding, inadequate legal recognition and uneven participation across Member States, and ERNs must be significantly strengthened and placed on a permanent, adequately resourced footing; | D. whereas the European Reference Networks (ERNs) sustainability is endangered by precarious funding and uneven participation across Member States, and ERNs must be significantly strengthened by their integration into national healthcare systems, systematic referral mechanisms, and placed on a permanent, adequately resourced footing; |
| Motion for a resolution | Amendment |
|---|---|
| D. whereas the European Reference Networks (ERNs) sustainability is endangered by precarious funding, inadequate legal recognition and uneven participation across Member States, and ERNs must be significantly strengthened and placed on a permanent, adequately resourced footing; | D. whereas the European Reference Networks (ERNs) sustainability is endangered by precarious funding, inadequate legal recognition and lack of integration with national health systems, and ERNs must be significantly strengthened and placed on a permanent, adequately resourced footing; |
| Motion for a resolution | Amendment |
|---|---|
| Da. whereas people living with rare diseases in the Union, estimated at between 27 and 36 million, or one in every 12 to 16 persons, currently face an average diagnostic delay of 4.7 years, rising to 10.4 years for children aged 10 to 20 and 1.7 years longer for women than for men; whereas, as underlined in the Committee on Public Health's parallel own-initiative report on an EU Rare Disease Action Plan (2025/2130(INL)), the central obstacle facing these patients is not primarily scientific but structural and organisational in nature, calling for a coordinated Union framework rather than fragmented national responses; whereas the European Reference Networks are, on this basis, a central engine of Union added value for rare and complex diseases and must be treated as such throughout this Directive; |
| Motion for a resolution | Amendment |
|---|---|
| Da. whereas bureaucratic complexity, as well as the introduction of new digital channels in procedures for cross-border reimbursement of healthcare costs, can make it difficult for citizens, especially older people, to obtain effective access to the cover and benefits to which they are entitled; |
| Motion for a resolution | Amendment |
|---|---|
| E. whereas National Contact Points (NCPs), are chronically under-staffed, inconsistently structured and too often practically inaccessible to patients with lower digital literacy, disabilities or language barriers; | E. whereas National Contact Points (NCPs), are chronically under-staffed, inconsistently structured and too often practically inaccessible to patients with lower digital literacy, disabilities or language barriers; whereas as of 2023, only two Member States offered NCP information in a third language beyond English and their native language, and only seven provided accessible options for persons with decreased visual sensory functions, representing a failure to comply with the transparency and accessibility requirements of Directive 2011/24/EU read in combination with Article 26 of the Charter of Fundamental Rights; |
| Motion for a resolution | Amendment |
|---|---|
| E. whereas National Contact Points (NCPs), are chronically under-staffed, inconsistently structured and too often practically inaccessible to patients with lower digital literacy, disabilities or language barriers; | E. whereas National Contact Points (NCPs), as the primary information interface between the cross-border healthcare system and patients, are chronically under-staffed, inconsistently structured and too often practically inaccessible to patients with lower digital literacy, disabilities or language barriers; this is evidenced by the fact that fewer than 20 % of citizens feel informed about their cross-border healthcare rights and only 10 % are aware of the existence of NCPs; without substantially strengthened NCPs, the entire system of patients' rights remains aspirational rather than real; |
| Motion for a resolution | Amendment |
|---|---|
| Ea. whereas citizens’ usage of their rights in Directive 2011/24/EU remains negligible, accounting for approximately 0.01 % of total government expenditure on healthcare. Whereas in Member States without a land border, and in island regions and islands the Directive is even more difficult to use due to a cumbersome reimbursement route , including the requirement to advance the full cost of treatment, combined with air travel costs that are not reimbursed and reimbursement capping at domestic rates; whereas Article 174 of the Treaty on the Functioning of the European Union requires the Union to pay particular attention to island regions; |
| Motion for a resolution | Amendment |
|---|---|
| Ea. whereas Recital 4 of Directive 2011/24/EU states that that Directive should not result in patients being encouraged to receive treatment outside their Member State of affiliation; whereas several of the measures proposed in this report risk transforming cross-border healthcare from a complementary option into a structurally promoted and publicly subsidised alternative to healthcare in the Member State of affiliation; |
| Motion for a resolution | Amendment |
|---|---|
| Ea. whereas the European Court of Auditors has concluded that EU actions in cross-border healthcare require improved management and effectiveness, and whereas stronger coordination at Union level is necessary to enhance health system resilience, reduce delays in access to cross-border healthcare, including treatment waiting times and delays linked to prior authorisation and reimbursement procedures; |
| Motion for a resolution | Amendment |
|---|---|
| Ea. whereas shortages of healthcare professionals act as a significant barrier to equitable and timely access to quality cross-border healthcare services; whereas WHO is expecting a shortfall of 4.1 million healthcare professionals in the EU by 2030 including 2.3 million nurses, 0.6 million physicians, and 1.3 million allied healthcare professionals; |
| Motion for a resolution | Amendment |
|---|---|
| Ea. whereas shortages of healthcare professionals act as a significant barrier to equitable and timely access to quality cross-border healthcare services; whereas WHO is expecting a shortfall of 4.1 million healthcare professionals in the EU by 2030 including 2.3 million nurses, 0.6 million physicians, and 1.3 million allied healthcare professionals; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| Ea. whereas NCPs remain largely unknown to both patients and healthcare providers; whereas healthcare providers often lack the adequate knowledge, including with regard to prior authorisation or reimbursement rules, which in turn undermines their ability to inform, guide and support patients seeking to exercise their cross-border healthcare rights; |
| Motion for a resolution | Amendment |
|---|---|
| Ea. whereas scientific and technological progress are introducing increasing numbers of specialised treatment and diagnostic options for previously incurable or untreatable conditions, and the provision of such care requires complex infrastructures that cannot be replicated in every country and treatment centre; |
| Motion for a resolution | Amendment |
|---|---|
| Ea. whereas shortages of healthcare professionals act as a significant barrier to equitable and timely access to quality cross-border healthcare services; |
| Motion for a resolution | Amendment |
|---|---|
| Eb. whereas Article 7(1) of Directive 2011/24/EU limits reimbursement to healthcare to the services covered in the Member State of affiliation, with the result that the Directive limits European patient rights to care already entitled at home rather than providing a right of access to established European standards of care; whereas the content of that right varies according to the capacity of individual Member States with the result that the Directive reproduces the inequalities between health systems which it was intended to relieve in the first place; whereas in smaller Member States a treatment is frequently absent from the national benefit basket simply because the Member State lacks the capacity to provide it, with the result that no allocative decision has been taken in its regard; whereas the Court of Justice has held that a condition requiring treatment to be normal in professional circles must be construed by reference to what is sufficiently tried and tested by international medical science rather than by reference to national practice, and that authorisation may be refused only where the same or equally effective treatment is available without undue delay in the Member State of affiliation; |
| Motion for a resolution | Amendment |
|---|---|
| Eb. whereas digitalisation and cross-border cooperation can improve access to healthcare services and medicines, these developments must be designed around patients’ needs and public health objectives, ensuring that innovation does not exacerbate existing inequalities or weaken local healthcare structures that are essential for equitable access to care; |
| Motion for a resolution | Amendment |
|---|---|
| Eb. whereas the rapid digitalisation of healthcare, including the rise of cross-border telemedicine and the development of the European Health Data Space (EHDS), offers unprecedented opportunities to improve continuity of care, but is currently hindered by fragmented national reimbursement policies and uneven interoperability. |
| Motion for a resolution | Amendment |
|---|---|
| Eb. whereas patients with rare and complex diseases often require highly specialised expertise that is not available in their Member State of residence and therefore require effective access to cross-border care and European Reference Networks; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| Eb. whereas the current system of reimbursement lacks clear and uniform reimbursement rules on digital cross-border healthcare provider-to-healthcare provider consultations; |
| Motion for a resolution | Amendment |
|---|---|
| Ec. whereas refusals of prior authorisation are often due to divergent clinical assessments as to efficiency or justifiable time-frame rather than the coverage of type or category of treatment concerned; whereas the Directive establishes no standard for that clinical assessment, does not require it to be made by a medical practitioner qualified in the relevant specialty, and provides no mechanism for resolving disagreements; whereas the case-law of the Court of Justice, in particular in Watts (C-372/04), Elchinov (C-173/09) and Petru (C-268/13), has established requirements in this regard which should become part of the Directive for application by the competent institutions; |
Liesbet Sommen, Pascal Arimont, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| Ec. whereas the European Health Data Space, established by Regulation (EU) 2025/327, has the potential to significantly improve patients' access to cross-border healthcare by enabling the secure, efficient and interoperable exchange of electronic health data; whereas the success of the EHDS is contingent on the uniform implementation across Member States; whereas the fragmented implementation would risk exacerbating the existing practical and administrative hurdles in accessing cross-border healthcare instead of resolving them; |
| Motion for a resolution | Amendment |
|---|---|
| Ec. whereas telemedicine can contribute to improving the accessibility, continuity and quality of healthcare, including across borders, and whereas its wider uptake remains hindered by barriers such as differences in reimbursement and the need to further improve the quality and accessibility of telemedicine services, as well as to identify the situations in which telemedicine can provide an appropriate and effective alternative to in-person care; |
| Motion for a resolution | Amendment |
|---|---|
| Ec. whereas children, persons with disabilities and patients in vulnerable socio-economic situations may face disproportionate financial, administrative, geographical and informational barriers to exercising their rights to cross-border healthcare; |
| Motion for a resolution | Amendment |
|---|---|
| Ec. whereas shortages of healthcare professionals act as a significant barrier to equitable and timely access to quality cross-border healthcare services; |
| Motion for a resolution | Amendment |
|---|---|
| Ed. whereas a marketing authorisation valid throughout the Union confers a right to place a medicinal product on the market but imposes no obligation to do so, with the result that products authorised for the whole Union are in practice frequently unobtainable in Member States whose markets are too small to repay the cost of national launch; whereas approximately one third of all medicine registrations in some smaller Member States take place under Article 126a of Directive 2001/83/EC; whereas the recognition of prescriptions guaranteed by Article 11 of Directive 2011/24/EU is of no effect where the medicinal product prescribed holds no authorisation in the Member State of affiliation; and whereas the unavailability of a medicinal product is a principal cause of the failure of continuity of care following treatment in another Member State; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| Ed. whereas, according to the European Commission report on Member State data on cross-border patient healthcare, major flows of patients involve mostly neighbouring regions; whereas approximately one third of the Union’s population lives in a border region and, for those citizens, obtaining healthcare in a neighbouring Member State is not an exceptional act of patient mobility but a routine and structural feature of everyday life, since in many border regions, the nearest healthcare provider is often situated in another Member State; whereas, for patients belonging to a national linguistic minority in a border region, the nearest healthcare provider working in their own language is sometimes situated on the other side of the border; |
| Motion for a resolution | Amendment |
|---|---|
| Ed. whereas Article 35 of the Charter of Fundamental Rights of the European Union recognises the right of everyone to access preventive healthcare and to benefit from medical treatment, and whereas Article 26 recognises and respects the right of persons with disabilities to benefit from measures designed to ensure their independence, social and occupational integration and participation in their local communities and civil life; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak
| Motion for a resolution | Amendment |
|---|---|
| Ee. whereas Directive 2011/24/EU and Regulation (EC) No 883/2004 apply in parallel and produce materially different outcomes as regards prior authorisation, the choice of provider, the applicable tariffs and the obligation to advance costs; whereas Directive 2011/24/EU was conceived around the model of an individual patient travelling abroad on an exceptional basis for a specific treatment, and is therefore poorly suited to the reality of habitual, recurrent and frequently unplanned cross-border care in border regions; whereas in practice this means that in border regions, patients can rarely access the geographically closest healthcare based on the entitlements of their Member State of affiliation; |
| Motion for a resolution | Amendment |
|---|---|
| Ee. whereas scientific and technological progress is increasing the number of specialised diagnostic and treatment options requiring expertise, infrastructure and patient volumes which cannot be replicated in every Member State; whereas this structural constraint affects small and island Member States in particular and makes planned and structured European cross-border healthcare an essential complement to, rather than a substitute for, sustainable national capacity; |
| Motion for a resolution | Amendment |
|---|---|
| Ee. whereas the digitalisation of healthcare, including telemedicine, e-prescriptions and the European Health Data Space, offers significant opportunities to improve continuity of care and access to healthcare across borders, but requires interoperable, secure and patient-centred infrastructure; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| Ef. whereas, based on the current Directive 2011/24, a number of border regions have developed arrangements allowing residents of a defined area to obtain care on the other side of the border without prior authorisation and without advance payment; whereas these arrangements nevertheless remain voluntary, unevenly distributed along the Union’s internal borders, dependent on the goodwill of national administrations and liable to be restricted or terminated unilaterally, exposing the populations concerned to a sudden and severe reduction in access to care; |
| Motion for a resolution | Amendment |
|---|---|
| Ef. whereas patients remain insufficiently aware of their rights under Directive 2011/24/EU and face significant differences between Member States in reimbursement procedures, prior authorisation, access to information and the functioning of National Contact Points; |
Liesbet Sommen, Pascal Arimont, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| Eg. whereas, in border regions, the emergency unit able to reach a patient first is sometimes one stationed in a neighbouring Member State; whereas the cross border deployment of such emergency services continues to rest on a patchwork of regional agreements rather than a secure legal basis; |
| Motion for a resolution | Amendment |
|---|---|
| Eg. whereas serious cross-border threats to health and other exceptional circumstances may require rapid transfers of patients, healthcare professionals and medical supplies across borders and demonstrate the importance of effective European solidarity mechanisms; |
| Motion for a resolution | Amendment |
|---|---|
| 1. Calls on the Commission to present a modernised legislative framework on cross-border healthcare, also mobilising financial instruments, aimed at guaranteeing equitable and timely access to quality healthcare services throughout the Union, reducing administrative and financial barriers between regions and Member States, and ensuring that all patients have access to high quality care regardless of where they live; | 1. Calls on the Commission to present a modernised and patient-centred legislative framework on cross-border healthcare, supported by financial instruments, aimed at guaranteeing equitable, affordable and timely access to quality healthcare services throughout the Union, particularly for patients requiring highly specialised care, including those affected by cancer and rare diseases, reducing administrative and financial barriers between regions and Member States, and ensuring that all patients have access to high quality care regardless of where they live or their socioeconomic situation; |
| Motion for a resolution | Amendment |
|---|---|
| 1. Calls on the Commission to present a modernised legislative framework on cross-border healthcare, also mobilising financial instruments, aimed at guaranteeing equitable and timely access to quality healthcare services throughout the Union, reducing administrative and financial barriers between regions and Member States, and ensuring that all patients have access to high quality care regardless of where they live; | 1. Calls on the Commission to present a modernised legislative framework on cross-border healthcare, reducing administrative barriers between Member States; recalls that, pursuant to Article 168(7) TFEU, responsibility for the definition of health policy and for the organisation, management and allocation of resources within health services and medical care rests with the Member States; stresses that the framework for cross-border healthcare must facilitate patient mobility without harmonising national healthcare systems, benefit entitlements, reimbursement rules or healthcare priorities; |
| Motion for a resolution | Amendment |
|---|---|
| 1. Calls on the Commission to present a modernised legislative framework on cross-border healthcare, also mobilising financial instruments, aimed at guaranteeing equitable and timely access to quality healthcare services throughout the Union, reducing administrative and financial barriers between regions and Member States, and ensuring that all patients have access to high quality care regardless of where they live; | 1. Calls on the Commission to present a modernised legislative framework on cross-border healthcare, also mobilising financial instruments, aimed at guaranteeing equitable and timely access to quality healthcare services throughout the Union, reducing administrative and financial barriers between regions and Member States, ensuring greater legal clarity and coherence between Directive 2011/24/EU and Regulations (EC) No 883/2004 and (EC) No 987/2009 and ensuring that all patients have access to high quality care regardless of where they live; |
| Motion for a resolution | Amendment |
|---|---|
| 1. Calls on the Commission to present a modernised legislative framework on cross-border healthcare, also mobilising financial instruments, aimed at guaranteeing equitable and timely access to quality healthcare services throughout the Union, reducing administrative and financial barriers between regions and Member States, and ensuring that all patients have access to high quality care regardless of where they live; | 1. Calls on the Commission to present a modernised legislative framework on cross-border healthcare, also mobilising financial instruments, aimed at guaranteeing equitable and timely access to quality healthcare services throughout the Union, reducing administrative and financial barriers between regions and Member States, and ensuring that all patients have access to high quality care regardless of where they live and their level of personal income or wealth; |
| Motion for a resolution | Amendment |
|---|---|
| 1. Calls on the Commission to present a modernised legislative framework on cross-border healthcare, also mobilising financial instruments, aimed at guaranteeing equitable and timely access to quality healthcare services throughout the Union, reducing administrative and financial barriers between regions and Member States, and ensuring that all patients have access to high quality care regardless of where they live; | 1. Calls on the Commission to present a modernised legislative framework on cross-border healthcare with a view to facilitating timely and equitable access to safe and high-quality cross-border healthcare, simplifying administrative procedures and reducing financial barriers faced by patients; calls on the Commission and the Member States to mobilise relevant Union and national financial instruments to support cross-border cooperation and contribute to a sustainable and resilient healthcare workforce; |
| Motion for a resolution | Amendment |
|---|---|
| 1. Calls on the Commission to present a modernised legislative framework on cross-border healthcare, also mobilising financial instruments, aimed at guaranteeing equitable and timely access to quality healthcare services throughout the Union, reducing administrative and financial barriers between regions and Member States, and ensuring that all patients have access to high quality care regardless of where they live; | 1. Calls on the Commission to present a modernised legislative framework on cross-border healthcare, also mobilising financial instruments, aimed at guaranteeing equitable and timely access to quality healthcare services throughout the Union, reducing administrative and financial barriers between regions and Member States, and ensuring that all patients have genuine opportunity to utilize and benefit from cross-border healthcare and access to high quality care regardless of where they live; |
| Motion for a resolution | Amendment |
|---|---|
| 1. Calls on the Commission to present a modernised legislative framework on cross-border healthcare, also mobilising financial instruments, aimed at guaranteeing equitable and timely access to quality healthcare services throughout the Union, reducing administrative and financial barriers between regions and Member States, and ensuring that all patients have access to high quality care regardless of where they live; | 1. Calls on the Commission to present a modernised legislative framework on cross-border healthcare, also mobilising financial instruments, aimed at guaranteeing equitable and timely access to quality healthcare services throughout the Union, reducing administrative and financial barriers between regions and Member States, and ensuring that all patients have access to high quality care regardless of where they live, and their level of personal income or wealth; |
Valérie Deloge, Aleksandar Nikolic, Laurent Castillo, Margarita de la Pisa Carrión, Marie-Luce Brasier-Clain
| Motion for a resolution | Amendment |
|---|---|
| 1. Calls on the Commission to present a modernised legislative framework on cross-border healthcare, also mobilising financial instruments, aimed at guaranteeing equitable and timely access to quality healthcare services throughout the Union, reducing administrative and financial barriers between regions and Member States, and ensuring that all patients have access to high quality care regardless of where they live; | 1. Calls on the Commission to present targeted amendments to the framework on cross-border healthcare in order to facilitate the exercise of patients’ existing rights and to reduce unjustified administrative barriers, whilst fully respecting the Member States’ responsibilities for the organisation, management, funding and provision of health services and medical care; |
| Motion for a resolution | Amendment |
|---|---|
| 1. Calls on the Commission to present a modernised legislative framework on cross-border healthcare, also mobilising financial instruments, aimed at guaranteeing equitable and timely access to quality healthcare services throughout the Union, reducing administrative and financial barriers between regions and Member States, and ensuring that all patients have access to high quality care regardless of where they live; | 1. Calls on the Commission to present a modernised legislative framework on cross-border healthcare aimed at guaranteeing equitable and timely access to quality healthcare services throughout the Union, reducing administrative and financial barriers between regions and Member States, and ensuring that all patients have access to high quality care regardless of where they live; |
| Motion for a resolution | Amendment |
|---|---|
| 1. Calls on the Commission to present a modernised legislative framework on cross-border healthcare, also mobilising financial instruments, aimed at guaranteeing equitable and timely access to quality healthcare services throughout the Union, reducing administrative and financial barriers between regions and Member States, and ensuring that all patients have access to high quality care regardless of where they live; | 1. Calls on the Commission to present a modernised legislative framework on cross-border healthcare, also mobilising financial instruments, aimed at guaranteeing equitable and timely access to quality healthcare services throughout the Union, reducing administrative and financial barriers between regions and Member States, and ensuring that all patients have equal access to high quality care regardless of where they live; |
| Motion for a resolution | Amendment |
|---|---|
| 1a. Calls on the Commission to include provisions that specifically address the needs of people living with rare and complex conditions, removing up-front payments, establishing a standardised time-bound cross-border clinical and administrative care pathway, ensuring comprehensive coverage for diagnostic tests, medical interventions, follow-up care and non-clinical expenses that must be incurred to access care abroad, as well as support for families and patients to navigate the cross-border healthcare system; |
| Motion for a resolution | Amendment |
|---|---|
| 1a. Measures introduced pursuant to this Directive should fully respect Member States’ competences for the organisation and financing of their healthcare systems. They should not impose new financial or administrative burdens on healthcare providers and, where relevant, should be supported by clearly allocated responsibilities and appropriate financing arrangements; |
| Motion for a resolution | Amendment |
|---|---|
| 1a. Calls on the Commission to establish a European Cross-Border Healthcare “One-Stop Shop”, integrated with the Your Europe portal and existing National Contact Points, providing information on patients' rights, healthcare providers, prior authorisation, reimbursement and additional expenses, quality and safety, and complaint and redress mechanisms; |
| Motion for a resolution | Amendment |
|---|---|
| 1a. Stresses that the successful implementation of the EU cross-border healthcare directive requires strong and resilient public health systems; |
| Motion for a resolution | Amendment |
|---|---|
| 1b. Encourages the adoption of a limited core set of EU quality and safety indicators, scoreboards and monitoring tools and time-bound targets to assess progress, identify gaps and support policy learning aimed at reducing cross-border inequalities in access to diagnosis, treatment and care and medical rehabilitation across the Union, including targeted financial and technical support for Member States with limited diagnostic capacity, specialised centres or treatment availability; |
| Motion for a resolution | Amendment |
|---|---|
| 1b. Calls on the Commission and Member States to establish a European capacity-building programme for National Contact Points and relevant intermediaries and to conduct periodic EU-level reviews of NCPs' websites, ensuring consistent application of tools and templates and providing tailored recommendations to Member States to address inconsistencies; |
| Motion for a resolution | Amendment |
|---|---|
| 2. Stresses that patient organisations must be formally involved in the operation and governance of National Contact Points (NCPs) to ensure that the information provided meets the real-life needs of patients; stresses the importance of ensuring sustainable, objective and transparent public funding for patients’ organisations to enable their presence in the public sphere and governance structures, and to provide them with financial independence; | 2. Stresses that patient organisations must be formally involved in the operation, co-design, and governance of National Contact Points (NCPs) and Case Navigator Services to ensure that information and active support pathways meet the real-life needs of patients; stresses the importance of ensuring sustainable, objective, and transparent public funding for patients’ organisations to recognize and compensate their indispensable role in offering navigation services, translating clinical documents, coordinating travel logistics, overcoming language barriers, and providing psychosocial support, thereby integrating them as formal, compensated partners within national healthcare navigation systems; |
| Motion for a resolution | Amendment |
|---|---|
| 2. Stresses that patient organisations must be formally involved in the operation and governance of National Contact Points (NCPs) to ensure that the information provided meets the real-life needs of patients; stresses the importance of ensuring sustainable, objective and transparent public funding for patients’ organisations to enable their presence in the public sphere and governance structures, and to provide them with financial independence; | 2. Stresses that patient organisations and health professional associations must be formally involved in the operation and governance of National Contact Points (NCPs) to ensure that the information provided meets the real-life needs of patients and that health professionals can adequately inform and guide patients and citizens; stresses the importance of ensuring sustainable, objective and transparent public funding for patients’ organisations and health professional associations to enable their presence in the public sphere and governance structures, and to provide them with financial independence; |
| Motion for a resolution | Amendment |
|---|---|
| 2. Stresses that patient organisations must be formally involved in the operation and governance of National Contact Points (NCPs) to ensure that the information provided meets the real-life needs of patients; stresses the importance of ensuring sustainable, objective and transparent public funding for patients’ organisations to enable their presence in the public sphere and governance structures, and to provide them with financial independence; | 2. Stresses that patient organisations must be formally involved in the governance, monitoring and evaluation of National Contact Points (NCPs) to ensure that the information provided meets the real-life needs of patients and that health professionals can adequately inform and guide patients and citizens; stresses the importance of ensuring sustainable, objective and transparent public funding for patients’ organisations and health professional associations to enable their meaningful participation in the public sphere and governance structures, and to provide them with financial independence; |
| Motion for a resolution | Amendment |
|---|---|
| 2. Stresses that patient organisations must be formally involved in the operation and governance of National Contact Points (NCPs) to ensure that the information provided meets the real-life needs of patients; stresses the importance of ensuring sustainable, objective and transparent public funding for patients’ organisations to enable their presence in the public sphere and governance structures, and to provide them with financial independence; | 2. Stresses that patient organisations and health professional associations should be meaningfully and structurally involved in the operation and governance of National Contact Points (NCPs), in order to ensure that the information provided reflects patients’ real-life needs and enables health professionals to inform and guide them effectively; stresses the importance of ensuring adequate, sustainable and transparent public funding for patient organisations to enable their effective participation in relevant public and governance structures; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak
| Motion for a resolution | Amendment |
|---|---|
| 2. Stresses that patient organisations must be formally involved in the operation and governance of National Contact Points (NCPs) to ensure that the information provided meets the real-life needs of patients; stresses the importance of ensuring sustainable, objective and transparent public funding for patients’ organisations to enable their presence in the public sphere and governance structures, and to provide them with financial independence; | 2. Stresses that patient organisations, health professional associations, healthcare providers and healthcare insurers must be formally involved in the operation and governance of National Contact Points (NCPs) to ensure that the information provided meets the real-life needs of patients; stresses the importance of ensuring sustainable, objective and transparent public funding for patients’ organisations to enable their presence in the public sphere and governance structures, and to provide them with financial independence; |
| Motion for a resolution | Amendment |
|---|---|
| 2. Stresses that patient organisations must be formally involved in the operation and governance of National Contact Points (NCPs) to ensure that the information provided meets the real-life needs of patients; stresses the importance of ensuring sustainable, objective and transparent public funding for patients’ organisations to enable their presence in the public sphere and governance structures, and to provide them with financial independence; | 2. Stresses that patient and healthcare professional organisations must be formally involved in the operation and governance of National Contact Points (NCPs) to ensure that the information provided meets the real-life needs of patients; stresses the importance of ensuring sustainable, objective and transparent public funding for patients’ organisations to enable their presence in the public sphere and governance structures, and to provide them with financial independence; |
| Motion for a resolution | Amendment |
|---|---|
| 2. Stresses that patient organisations must be formally involved in the operation and governance of National Contact Points (NCPs) to ensure that the information provided meets the real-life needs of patients; stresses the importance of ensuring sustainable, objective and transparent public funding for patients’ organisations to enable their presence in the public sphere and governance structures, and to provide them with financial independence; | 2. Considers that national contact points may consult representative patient organisations, healthcare providers and insurers where appropriate; stresses that such cooperation must be transparent and subject to clear rules on representativeness, conflicts of interest and sources of funding; rejects any automatic entitlement to public funding or representation in governing structures; |
| Motion for a resolution | Amendment |
|---|---|
| 2a. Member States shall ensure that National Contact Points (NCPs) are structurally integrated and formally connected with European Reference Networks (ERNs), National Reference Networks, designated rare disease Centres of Expertise, and national rare disease patient alliances within their territory. NCPs shall operate as active information resources on cross-border healthcare and primary nodes of contact for the rare disease patient community and healthcare professionals. To ensure a uniform and reliable level of support across the Union, the Commission shall establish minimum quality, accessibility, and content standards for NCP services. These standardsshall include mandatory maximum response time obligations for inquiries related to rare diseases. All information, documentation, and guidance provided by NCPs shall be made publicly available in the official language(s) of the Member State and in English. NCPs shall provide specific, clear, and practical guidance tailored to rare disease patients, detailing: (a) the criteria and procedural steps for obtaining prior authorisation; (b) the specific pathways and timelines for financial reimbursement; and (c) the available administrative and legal remedies in the event of a denial of authorisation or reimbursement; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| 2a. Stresses that National Contact Points should also act as central point of information for patients in their Member State of affiliation in order to protect patients from misleading, unsafe or insufficiently evidenced healthcare offers marketed across borders, including through online channels. National Contact Points should, together with patient organisations, competent health and consumer protection authorities, provide patients seeking treatment abroad with independent, evidence-based information on cross-border healthcare, enabling them to assess the credibility, regulatory status and scientific basis of treatments; |
| Motion for a resolution | Amendment |
|---|---|
| 2a. Stresses that patient organisations must be formally involved in the operation and governance of National Contact Points (NCPs); Recognises that the obligations placed on National Contact Points must be proportionate to the administrative capacity of smaller Member States, and calls on the Commission to enable and support the voluntary pooling of National Contact Point functions between Member States, so that those obligations are discharged in practice rather than transposed formally; |
| Motion for a resolution | Amendment |
|---|---|
| 2a. Calls on the Member States to ensure that National Contact Points (NCPs) are structurally integrated and formally connected with ERNs, National Reference Networks, designated rare disease Centres of Expertise, and national rare disease patient alliances within their territory; stresses the importance of establishing an EU-wide procedure for NCPs to seek expert advice to inform prior authorisation decisions for requests referred to people living with rare and complex conditions; |
| Motion for a resolution | Amendment |
|---|---|
| 2a. Stresses that patients must receive clear, complete, up-to-date and impartial information on the available pathways for accessing cross-border healthcare, including the applicable conditions, reimbursement arrangements and potential financial implications; underlines that patients should not be unduly steered towards private healthcare providers and must be enabled to make a genuinely free and informed choice; |
| Motion for a resolution | Amendment |
|---|---|
| 2a. Calls on the Commission to include telemedicine in the modernised legislative framework on cross-border healthcare; |
| Motion for a resolution | Amendment |
|---|---|
| 2b. Calls on the Commission to assess the feasibility of establishing a genuine EU-level one-stop shop for cross-border healthcare information, modelled on the ECC-Net architecture, providing citizens with a single, reliable and multilingual entry point for guidance on their cross-border healthcare rights prior to referral to the relevant national procedures and competent authorities, with a view to eliminating the informational fragmentation that continues to deter patients from effectively exercising the rights conferred upon them under Union law; |
| Motion for a resolution | Amendment |
|---|---|
| 2b. Calls on the Commission to define complaint and redress mechanisms for cross-border healthcare, including competent authorities, maximum decision times, appeal procedures, alternative dispute resolution mechanisms and EU-level monitoring and mechanism for complaints; calls for these mechanisms to build on existing EU structures such as SOLVIT and Alternative Dispute Resolutions Networks; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| 2b. Calls on the Commission to examine the merits of setting up an EU level one-stop shop drawing on the model of the European Consumers Centres Network, bringing together national cross-border healthcare information, thereby addressing the dispersed and inconsistent information landscape by acting as a single point of contact for cross-border healthcare entitlements; |
| Motion for a resolution | Amendment |
|---|---|
| 2b. Calls on Member States to ensure that healthcare providers have access to clear and up-to-date information on patients’ rights to cross-border healthcare and the applicable procedures and reimbursement pathways, enabling them to provide appropriate guidance to patients; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| 2c. Calls on the Commission to clarify, in the revised legislative framework, the relationship between Directive 2011/24/EU and Regulation (EC) No 883/2004 by requiring competent institutions and National Contact Points to inform every applicant, before a request is decided, how their case would be treated under each of the two instruments and which of them is more favourable in their specific situation; considers that a patient should not lose an entitlement solely because a request was submitted under one instrument rather than the other, and that competent institutions should be required to examine a request under the more favourable instrument; |
| Motion for a resolution | Amendment |
|---|---|
| 3. Stresses that healthcare must remain a public good based on solidarity and equitable access; Calls on the Commission and Member States to introduce robust safeguards, including by addressing barriers like the upfront payments with the aim of ensuring equitable access to cross-border healthcare services for all, regardless of nationality, socioeconomic status, disability, gender identity or place of residence; | 3. Stresses that healthcare must remain a public good based on solidarity and equitable access; Calls on the Commission and Member States to introduce robust safeguards, including by addressing barriers like the upfront payments with the aim of ensuring equitable access to cross-border healthcare services for all, regardless of nationality, socioeconomic status, disability, gender identity or place of residence; insists that the modernised framework must include provisions protecting patient families against socio-economic disruptions, including loss of income, job insecurity, or loss of national residency and social security benefits in the lead-up to, during, and after prolonged cross-border treatments; |
| Motion for a resolution | Amendment |
|---|---|
| 3. Stresses that healthcare must remain a public good based on solidarity and equitable access; Calls on the Commission and Member States to introduce robust safeguards, including by addressing barriers like the upfront payments with the aim of ensuring equitable access to cross-border healthcare services for all, regardless of nationality, socioeconomic status, disability, gender identity or place of residence; | 3. Stresses that healthcare must remain a public good based on solidarity and equitable access; Calls on the Commission and Member States to introduce robust safeguards, including by addressing barriers like the upfront payments with the aim of ensuring equitable access to cross-border healthcare services for all, regardless of nationality, socioeconomic status, disability, gender identity or place of residence, while safeguarding the financial sustainability and solidarity-based character of national healthcare systems and avoiding incentives that unduly steer patients from public or contracted healthcare provision towards private healthcare providers; |
| Motion for a resolution | Amendment |
|---|---|
| 3. Stresses that healthcare must remain a public good based on solidarity and equitable access; Calls on the Commission and Member States to introduce robust safeguards, including by addressing barriers like the upfront payments with the aim of ensuring equitable access to cross-border healthcare services for all, regardless of nationality, socioeconomic status, disability, gender identity or place of residence; | 3. Stresses that healthcare must remain a public good based on solidarity, universality and equitable access; Calls on the Commission and Member States to introduce robust safeguards, including by addressing barriers like the upfront payments, complex reimbursement procedures and lack of accessible information, with the aim of ensuring equitable access to cross-border healthcare services for all, regardless of nationality, socioeconomic status, disability, gender identity, age, language, digital literacy or place of residence; calls for specific support measures for vulnerable and underserved populations; |
| Motion for a resolution | Amendment |
|---|---|
| 3. Stresses that healthcare must remain a public good based on solidarity and equitable access; Calls on the Commission and Member States to introduce robust safeguards, including by addressing barriers like the upfront payments with the aim of ensuring equitable access to cross-border healthcare services for all, regardless of nationality, socioeconomic status, disability, gender identity or place of residence; | 3. Stresses that healthcare must remain a public good based on solidarity and equitable access; Calls on the Commission and Member States to introduce robust safeguards, including by addressing barriers like the upfront payments and shortages of healthcare professionals with the aim of ensuring equitable access to cross-border healthcare services for all, regardless of nationality, socioeconomic status, disability, gender identity or place of residence; |
| Motion for a resolution | Amendment |
|---|---|
| 3. Stresses that healthcare must remain a public good based on solidarity and equitable access; Calls on the Commission and Member States to introduce robust safeguards, including by addressing barriers like the upfront payments with the aim of ensuring equitable access to cross-border healthcare services for all, regardless of nationality, socioeconomic status, disability, gender identity or place of residence; | 3. Stresses that healthcare must remain a public good based on solidarity and equitable access; Calls on the Commission and Member States to introduce robust safeguards, including by addressing barriers like the upfront payments and interoperable reimbursement frameworks with the aim of ensuring equitable access to cross-border healthcare services for all, regardless of nationality, socioeconomic status, disability, gender identity or place of residence; |
| Motion for a resolution | Amendment |
|---|---|
| 3. Stresses that healthcare must remain a public good based on solidarity and equitable access; Calls on the Commission and Member States to introduce robust safeguards, including by addressing barriers like the upfront payments with the aim of ensuring equitable access to cross-border healthcare services for all, regardless of nationality, socioeconomic status, disability, gender identity or place of residence; | 3. Stresses that healthcare must remain a public good based on solidarity and equitable access; Calls on the Commission and Member States to introduce robust safeguards, including by addressing barriers like the upfront payments with the aim of ensuring equitable access to cross-border healthcare services for all, regardless of nationality, socioeconomic status, disability, gender identity, sexual orientation or place of residence; |
Valérie Deloge, Aleksandar Nikolic, Laurent Castillo, Margarita de la Pisa Carrión, Marie-Luce Brasier-Clain
| Motion for a resolution | Amendment |
|---|---|
| 3. Stresses that healthcare must remain a public good based on solidarity and equitable access; Calls on the Commission and Member States to introduce robust safeguards, including by addressing barriers like the upfront payments with the aim of ensuring equitable access to cross-border healthcare services for all, regardless of nationality, socioeconomic status, disability, gender identity or place of residence; | 3. Stresses that healthcare must remain a public good based on solidarity and equitable access; calls on the Commission and Member States to introduce robust safeguards, reducing unjustified administrative and financial barriers, whilst respecting national arrangements for the funding and provision of healthcare, with the aim of ensuring equitable access to cross-border healthcare services for all; |
| Motion for a resolution | Amendment |
|---|---|
| 3. Stresses that healthcare must remain a public good based on solidarity and equitable access; Calls on the Commission and Member States to introduce robust safeguards, including by addressing barriers like the upfront payments with the aim of ensuring equitable access to cross-border healthcare services for all, regardless of nationality, socioeconomic status, disability, gender identity or place of residence; | 3. Stresses that healthcare must remain a public good based on solidarity and equitable access; Calls on the Commission and Member States to introduce robust safeguards, including by addressing barriers like the upfront payments with the aim of ensuring equitable access to cross-border healthcare services for all, regardless of nationality, socioeconomic status, disability, gender or place of residence; |
| Motion for a resolution | Amendment |
|---|---|
| 3. Stresses that healthcare must remain a public good based on solidarity and equitable access; Calls on the Commission and Member States to introduce robust safeguards, including by addressing barriers like the upfront payments with the aim of ensuring equitable access to cross-border healthcare services for all, regardless of nationality, socioeconomic status, disability, gender identity or place of residence; | 3. Stresses the importance of ensuring timely and equitable access to safe and high-quality cross-border healthcare and of addressing shortages of healthcare professionals; calls on the Commission and the Member States, within their respective competences, to introduce proportionate measures to reduce barriers arising from upfront payment requirements, particularly for patients in vulnerable situations; |
| Motion for a resolution | Amendment |
|---|---|
| 3. Stresses that healthcare must remain a public good based on solidarity and equitable access; Calls on the Commission and Member States to introduce robust safeguards, including by addressing barriers like the upfront payments with the aim of ensuring equitable access to cross-border healthcare services for all, regardless of nationality, socioeconomic status, disability, gender identity or place of residence; | 3. Stresses that healthcare must remain a public good based on solidarity and equitable access; Calls on the Commission and Member States to introduce robust safeguards, including by addressing barriers like the upfront payments, ensuring equitable access to cross-border healthcare services for all, regardless of nationality, socioeconomic status, disability, gender identity or place of residence; |
| Motion for a resolution | Amendment |
|---|---|
| 3a. Asks the Commission, in cooperation with the Member States, to draw up a strategy to enhance the attractiveness of European healthcare by promoting institutions with proven standards of quality, safety, innovation and specialisation; calls on the Member States to identify facilities with sufficient capacity to receive patients from other Member States and to develop transparent cross-border pathways, including by means of agreements between providers and the relevant insurance or healthcare bodies; stresses that any income from inbound healthcare mobility should contribute towards improving services, professional skills and healthcare infrastructure; |
| Motion for a resolution | Amendment |
|---|---|
| 3a. Stresses that pensioners and pension seekers who qualify as insured persons under Union law must be able to exercise their rights to planned cross-border healthcare on an equal basis, irrespective of whether they are formally affiliated to the healthcare insurance system of their Member State of residence; |
| Motion for a resolution | Amendment |
|---|---|
| 3b. Requests that the Commission and the Member States also view cross-border healthcare mobility as an opportunity to promote high-quality healthcare facilities and highly specialised centres within the Union; calls, to this end, for awareness-raising of, and access to, European clinical excellence, by means of multilingual information, interoperable digital tools, cooperation between healthcare providers and more effective operation of national contact points; stresses that increased capacity to attract patients from other Member States can contribute towards the sharing of expertise, the strengthening of research and innovation, and the sustainability of healthcare systems, provided that continuity of care, cost transparency and timely access to services for resident patients are ensured; |
| Motion for a resolution | Amendment |
|---|---|
| 4. Stresses the need to eliminate regional disparities while accessing to diagnosis, treatment and specialised expertise, including through strengthened European Reference Networks; | 4. Stresses the need to eliminate regional disparities while improving access to timely diagnosis, treatment and specialised expertise, including through strengthened European Reference Networks, and by establishing clearer referral and transfer pathways linking patients and referring clinicians to appropriately qualified specialised treatment centres, including centres administering ATMPs and, where relevant, future Centres of Excellence for advanced therapies; |
| Motion for a resolution | Amendment |
|---|---|
| 4. Stresses the need to eliminate regional disparities while accessing to diagnosis, treatment and specialised expertise, including through strengthened European Reference Networks; | 4. Stresses the need to eliminate regional disparities while accessing to diagnosis, treatment and specialised expertise, including through strengthened European Reference Networks and, where relevant, in alignment with developing EU health networks; stresses that patients should not be prevented from accessing necessary specialised expertise solely because such expertise is unavailable in their Member State of residence; |
Valérie Deloge, Aleksandar Nikolic, Laurent Castillo, Margarita de la Pisa Carrión, Marie-Luce Brasier-Clain
| Motion for a resolution | Amendment |
|---|---|
| 4. Stresses the need to eliminate regional disparities while accessing to diagnosis, treatment and specialised expertise, including through strengthened European Reference Networks; | 4. Stresses the particular importance of cross-border healthcare in border regions; encourages Member States, in particular neighbouring Member States, to build on existing bilateral or regional agreements and, where necessary, to conclude new ones with a view of facilitating access to healthcare; |
| Motion for a resolution | Amendment |
|---|---|
| 4. Stresses the need to eliminate regional disparities while accessing to diagnosis, treatment and specialised expertise, including through strengthened European Reference Networks; | 4. Stresses the need to eliminate regional disparities while accessing to diagnosis, treatment and specialised expertise, including through strengthened and adequately resourced European Reference Networks and a more resilient, domestically educated and trained EU healthcare workforce; |
| Motion for a resolution | Amendment |
|---|---|
| 4. Stresses the need to eliminate regional disparities while accessing to diagnosis, treatment and specialised expertise, including through strengthened European Reference Networks; | 4. Stresses the need to eliminate regional disparities while accessing to diagnosis, treatment and specialised expertise, including through strengthened European Reference Networks and a more resilient, domestically educated and trained EU healthcare workforce; |
| Motion for a resolution | Amendment |
|---|---|
| 4. Stresses the need to eliminate regional disparities while accessing to diagnosis, treatment and specialised expertise, including through strengthened European Reference Networks; | 4. Stresses the need to eliminate regional disparities while accessing to diagnosis, treatment and specialised expertise, including through strengthened ERNs, with an aim to ensure equitable geographical coverage of ERN through the Union; |
| Motion for a resolution | Amendment |
|---|---|
| 4a. Stresses that the Directive confers a right to receive abroad the healthcare to which a patient is entitled at home rather than a right of access to established European standards of care, and that this distinction is neither understood by patients nor explained to them before they travel; calls on the Commission to propose provisions, in accordance with the case-law of the Court of Justice, clarifying that where entitlement depends on a treatment being normal, appropriate or established, that condition is to be assessed by reference to what is sufficiently tried and tested by international medical science and not by reference to practice within the Member State of affiliation; that healthcare available in the Member State of affiliation does not preclude authorisation unless it is the same or equally effective treatment; and that where benefits are defined generically, authorisation may not be refused solely because the particular method is not practised domestically; further calls on the Commission to establish that where a treatment is not among the benefits provided in a Member State because that Member State lacks the capacity to provide it, rather than by reason of a decision not to fund it, the limitation in Article 7(1) shall not apply; and stresses that this does not extend to experimental or unproven treatment; |
| Motion for a resolution | Amendment |
|---|---|
| 4a. Calls on the Commission and the Member States to more vigorously enforce EU consumer-protection rules against misleading or aggressive commercial practices targeting patients in the EU and aimed at promoting planned treatment in third countries, in particular where essential information is omitted or unclearly presented in respect of professional qualifications, healthcare providers' authorisation and insurance cover, the quality and traceability of medicines, medical devices and materials used, post-treatment care or the available means of redress; stresses that price-based advertising must not obscure the information necessary for patients to make a safe and informed decision; |
| Motion for a resolution | Amendment |
|---|---|
| 4a. Stresses the need to eliminate regional disparities in accessing diagnosis, treatment and specialised expertise, including through strengthened European Reference Networks; underlines that no patient's chances of an accurate and timely diagnosis should depend on their Member State of residence, and calls for cross-border referral pathways to the ERNs to be systematically used to help close the current multi-year diagnostic delay faced by patients with rare and complex diseases, in full coherence with the objectives pursued by the Committee's parallel own-initiative report on an EU Rare Disease Action Plan; |
| Motion for a resolution | Amendment |
|---|---|
| 4a. Calls on the Commission to ensure that Member States require dispensing entities established on their territory to guarantee that medicinal products supplied to patients in another Member State are packaged, stored, handled and transported under conditions that safeguard their quality, safety and integrity throughout the delivery process. Such safeguards should ensure a level of protection equivalent in effect to that applicable within the regulated pharmaceutical supply chain and should be proportionate to the characteristics of the medicinal product and the risks linked to the chosen delivery rute; |
| Motion for a resolution | Amendment |
|---|---|
| 4a. Encourages a transition towards a person-centred, integrated approach to cross-border healthcare that tailors services to the comprehensive needs of individual patients, thereby empowering them and improving the overall management and continuity of their care; stresses, in this regard, the need for Member States to establish cross-border patient navigators to assist individuals and their families through complex medical, legal, and financial administrative processes; |
| Motion for a resolution | Amendment |
|---|---|
| 4a. Underlines the need to enable national and regional authorities to promote their centres of excellence as supporting entities in the development of European Reference Networks, thereby strengthening specialised care for patients with specific conditions, particularly rare diseases; |
| Motion for a resolution | Amendment |
|---|---|
| 4a. Recognises that disparities in awareness of cross-border healthcare rights among Member States, health systems, healthcare professionals, and patients can lead to unequal access in practice; stresses therefore the need to address information inequalities; |
| Motion for a resolution | Amendment |
|---|---|
| 4a. Stresses the importance of ensuring adequate and uninterrupted access to essential medicines in island and remote regions, including, where appropriate, by leveraging existing public infrastructure and dual-use infrastructure; |
| Motion for a resolution | Amendment |
|---|---|
| 4a. Welcomes the recognition of preventive healthcare in the revised framework and encourage the Commission to ensure that cross-border access provisions can also support continuity of preventive services, including for communicable diseases; |
| Motion for a resolution | Amendment |
|---|---|
| 4b. Emphasises that patient mobility must be understood primarily as a mechanism for solidarity, cooperation and the sharing of expertise between public healthcare systems, and not as a healthcare market instrument driven by competition between providers; |
| Motion for a resolution | Amendment |
|---|---|
| 4b. Calls on the Commission and Member States to fully leverage available and future Union funding instruments to substantially support public investment in healthcare infrastructure, public hospitals, primary care and preventive healthcare services; |
| Motion for a resolution | Amendment |
|---|---|
| 4b. Stresses the need for adequate staffing and reinforcement of health infrastructure in regions with significant seasonal population increases, especially during the tourist season; |
| Motion for a resolution | Amendment |
|---|---|
| 4c. Calls on the Commission to create an EU-level solidarity support mechanism specifically designed to assist Member States with fewer resources in meeting their obligations under the cross-border healthcare framework, including by providing financial assistance to cover upfront payments and out-of-pocket costs (such as travel and accommodation expenses) incurred by vulnerable patients, thereby ensuring that the system operates on the basis of genuine solidarity rather than imposing additional financial burdens on underfunded national health systems; |
| Motion for a resolution | Amendment |
|---|---|
| 4c. Calls the Commission and Member States to establish an adequate and comprehensive monitoring and evaluation framework for cross-border healthcare that can support evidence-based policy making and allow to disaggregate data by condition, socioeconomic status, gender, nationality and other relevant factors to measure equity of access; |
| Motion for a resolution | Amendment |
|---|---|
| 4d. Calls on Member States to urgently improve working conditions, salaries work-life balance and labour protections for healthcare workers across the Union, recognising that staff shortages, burnout and the emergence of “medical deserts” represent a structural threat to the sustainability of national health systems and, by extension, to patients' ability to access timely and quality care both domestically and across borders; |
| Motion for a resolution | Amendment |
|---|---|
| 4d. Recognises that disparities in awareness of cross-border healthcare rights among Member States, health systems, healthcare professionals, and patients can lead to unequal access in practice; stresses therefore the need to address information inequalities; |
| Motion for a resolution | Amendment |
|---|---|
| 4e. Stresses the importance of ensuring continuity of access to preventive healthcare services across Member States, including screening and prophylactic treatment for communicable diseases, in order to reduce health inequalities and support mobile populations throughout the Union; |
| Motion for a resolution | Amendment |
|---|---|
| 5. Calls on the Commission and Member States to reform the prior authorisation system to ensure it serves patients' needs rather than acting as an administrative gatekeeping mechanism; | 5. Calls on the Commission and Member States to reform the prior authorisation system to ensure it serves patients' needs rather than acting as an administrative gatekeeping mechanism, defining clear timeframes for the response of national authorities; calls on Member States to replace broad, vague categories with explicitly detailed public lists of the specific treatments subject to prior authorisation, having in consideration that prior authorisation should be strictly regarded as an exception to the cross-border healthcare mechanism; |
| Motion for a resolution | Amendment |
|---|---|
| 5. Calls on the Commission and Member States to reform the prior authorisation system to ensure it serves patients' needs rather than acting as an administrative gatekeeping mechanism; | 5. Calls on the Commission and Member States to reform the prior authorisation system to ensure it serves patients' needs rather than acting as an administrative gatekeeping mechanism; urges Member States to ensure that documented clinical urgency and rapidly progressing medical conditions are taken into account and that patients are not automatically denied reimbursement solely because prior authorisation could not reasonably be obtained before treatment in an urgent or life-threatening situation; |
| Motion for a resolution | Amendment |
|---|---|
| 5. Calls on the Commission and Member States to reform the prior authorisation system to ensure it serves patients' needs rather than acting as an administrative gatekeeping mechanism; | 5. Calls on the Commission and Member States to reform the prior authorisation system to ensure it serves patients' needs rather than acting as an administrative gatekeeping mechanism, including through transparent criteria, predictable and publicly available decision-making timelines and appropriate, expedited procedures where delay may materially affect clinical outcomes, in particular for people living with rare diseases and for patients requiring highly specialised treatments, such as ATMPs; |
| Motion for a resolution | Amendment |
|---|---|
| 5. Calls on the Commission and Member States to reform the prior authorisation system to ensure it serves patients' needs rather than acting as an administrative gatekeeping mechanism; | 5. Calls on the Commission and the Member States to ensure that prior-authorisation procedures are transparent, proportionate and processed without undue delay; recognises that such procedures may be necessary to enable Member States to plan healthcare capacity, control expenditure and maintain balanced and sustainable access to hospital and specialised care; |
| Motion for a resolution | Amendment |
|---|---|
| 5. Calls on the Commission and Member States to reform the prior authorisation system to ensure it serves patients' needs rather than acting as an administrative gatekeeping mechanism; | 5. Calls on the Commission and Member States to reform the prior authorisation system to serve patients' needs, without creating unjustified administrative barriers to access; |
| Motion for a resolution | Amendment |
|---|---|
| 5. Calls on the Commission and Member States to reform the prior authorisation system to ensure it serves patients' needs rather than acting as an administrative gatekeeping mechanism; | 5. Calls on the Commission and Member States to reform the prior authorisation system to ensure it serves patients' needs rather than acting as an unnecessary administrative gatekeeping mechanism; |
| Motion for a resolution | Amendment |
|---|---|
| 5a. Calls on the Commission and Member States to reform the prior authorisation system to ensure it serves patients' needs rather than acting as an administrative gatekeeping mechanism; Stresses that any decision refusing prior authorisation on the ground that adequate healthcare is available in the Member State of affiliation within a medically justifiable time limit must be based on an individual, objective medical assessment taking account of the patient’s current state of health, medical history, probable course of illness, degree of pain and nature of any disability; insists that the decision be reasoned in writing in clinical terms and be reassessed where the patient’s condition materially changes; |
| Motion for a resolution | Amendment |
|---|---|
| 5a. Calls on the Member States to establish a transparent reimbursement information and calculation system, covering reimbursable costs, ceilings, co-payments, exclusions and additional costs, with accessible online tools enabling patients to estimate in advance the amount eligible for reimbursement and their expected out-of-pocket costs, and to provide clear explanations for refusals or partial reimbursement; |
| Motion for a resolution | Amendment |
|---|---|
| 5a. Calls on the Commission and Member States to ensure that prior authorisation requirements are transparent, predictable, limited to what is necessary and proportionate, and do not constitute a means of arbitrary discrimination or an unjustified obstacle to the free movement of patients, while safeguarding Member States’ capacity to plan and manage their healthcare systems; |
| Motion for a resolution | Amendment |
|---|---|
| 5a. Calls the Commission to review and address obstacles that limit patients’ ability to obtain treatment abroad, through the EU cross-border framework, with centrally authorised Advanced Therapy Medicinal Products (ATMPs), recognising that these innovative medicines are particularily illustrative of shortcomings in the existing cross-border framework in the EU. |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| 5a. Calls on Member States to ensure that decisions on requests for prior authorisation are communicated to patients without undue delay and, wherever possible, through digital means, in writing, in a language the patient understands, and accompanied by a clear and comprehensible statement of the grounds on which authorisation has been granted or refused; |
| Motion for a resolution | Amendment |
|---|---|
| 5a. Recognises that disparities in awareness of cross-border healthcare rights among Member States, health systems, healthcare professionals, and patients can lead to unequal access in practice; stresses therefore the need to address information inequalities; |
| Motion for a resolution | Amendment |
|---|---|
| 5b. Calls on the Commission and Member States to reform the prior authorisation system to ensure it serves patients' needs and does not hinder, or create delays to, receiving care abroad, supporting effective patient mobility within the EU. |
| Motion for a resolution | Amendment |
|---|---|
| 6. Calls on Member States to replace broad, vague categories with explicitly detailed public lists of the specific treatments subject to prior authorisation; | deleted |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| 6. Calls on Member States to replace broad, vague categories with explicitly detailed public lists of the specific treatments subject to prior authorisation; | 6. Calls on Member States to replace broad, vague categories with explicitly detailed public lists of the specific treatments subject to prior authorisation, based on a list of common European indicators setting out minimum standards for information; calls on Member States to publish this list online and through the NCPs; |
| Motion for a resolution | Amendment |
|---|---|
| 6. Calls on Member States to replace broad, vague categories with explicitly detailed public lists of the specific treatments subject to prior authorisation; | 6. Calls on Member States to to ensure that the healthcare subject to prior authorisation, together with the applicable criteria and procedures, is clearly and publicly described and regularly updated, with sufficient detail to enable patients and healthcare professionals to determine in advance whether prior authorisation is required; |
| Motion for a resolution | Amendment |
|---|---|
| 6. Calls on Member States to replace broad, vague categories with explicitly detailed public lists of the specific treatments subject to prior authorisation; | 6. Calls on Member States to replace broad and unclear categories with comprehensive, publicly available and regularly updated lists of the specific healthcare services and treatments subject to prior authorisation , accompanied by clear information on applicable procedures and timelines; |
| Motion for a resolution | Amendment |
|---|---|
| 6a. Calls on the Commission to clarify the application of Directive 2011/24/EU to unplanned necessary healthcare and to ensure that patients are not denied reimbursement solely because prior authorisation could not reasonably have been obtained before medically necessary treatment was provided; |
| Motion for a resolution | Amendment |
|---|---|
| 6a. Calls on Member States to ensure that all prior authorisation decisions are issued in writing, with full and comprehensible reasons, in the patient's language, and with explicit information on the patient's rights of appeal and the procedure for exercising them; |
| Motion for a resolution | Amendment |
|---|---|
| 6a. Calls for binding maximum deadlines for decisions on prior authorisation, with accelerated procedures for urgent and time-sensitive cases, taking particular account of children and patients with rare or complex diseases; |
| Motion for a resolution | Amendment |
|---|---|
| 6a. Calls on Member States to enhance the transparency of the approval process for reimbursement requests; |
| Motion for a resolution | Amendment |
|---|---|
| 6b. Calls for the specific health situation, urgency and individual circumstances of the patient to be duly taken into account when decisions on prior authorisation are made, and for patients not to be disadvantaged by administrative delays beyond their control; |
| Motion for a resolution | Amendment |
|---|---|
| 6c. Calls for the revised framework to prevent the Member States of affiliations from imposing redundant or duplicative medical assessments as a condition for reimbursement where the patient's diagnosis and clinical need have already been established by appropriately qualified healthcare professionals in the Member State of treatment, unless objectively justified by patient-safety considerations; |
| Motion for a resolution | Amendment |
|---|---|
| 6d. Calls for simplified procedures for patients requiring recurring or long-term cross-border healthcare, including through multiannual and renewable authorisations where clinically appropriate; |
| Motion for a resolution | Amendment |
|---|---|
| 7. Calls on the Commission to establish minimum European standards for patients’ rights, including the right to timely treatment, informed consent and non-discrimination as well as seamless cross-border access to electronic medical records through the mandatory implementation of the European Health Data Space (EHDS); | 7. Calls on the Commission to establish minimum European standards for patients’ rights, including the right to timely treatment, including access to medicinal products, informed consent and non-discrimination, and to ensure that cross-border healthcare is supported by the seamless exchange of personal electronic health data, including patient summaries, ePrescriptions, medical imaging, medical test results and discharge reports, through the implementation of the European Health Data Space (EHDS), thereby improving patient safety and continuity of care across Member States; |
| Motion for a resolution | Amendment |
|---|---|
| 7. Calls on the Commission to establish minimum European standards for patients’ rights, including the right to timely treatment, informed consent and non-discrimination as well as seamless cross-border access to electronic medical records through the mandatory implementation of the European Health Data Space (EHDS); | 7. Calls on the Commission to establish minimum European standards for patients’ rights to ensure the effective exercise thereof under the Union cross-border healthcare framework, including the right to timely and transparent access to cross-border healthcare, informed consent and non-discrimination, as well as timely and secure access by patients and healthcare professionals to the electronic health data necessary for cross-border diagnosis, treatment and continuity of care, in accordance with Regulation (EU) 2025/327 on the European Health Data Space (EHDS); |
| Motion for a resolution | Amendment |
|---|---|
| 7. Calls on the Commission to establish minimum European standards for patients’ rights, including the right to timely treatment, informed consent and non-discrimination as well as seamless cross-border access to electronic medical records through the mandatory implementation of the European Health Data Space (EHDS); | 7. Calls on the Commission to establish minimum European standards for patients’ rights, including the right to timely treatment, informed consent and non-discrimination as well as seamless cross-border access to electronic medical health data (including patient summaries, ePrescriptions,eDispensations, medical imaging, medical test results and discharge reports) through the implementation of the European Health Data Space (EHDS) while safeguarding patients' fundamental rights of privacy and personal data protection; |
Valérie Deloge, Aleksandar Nikolic, Laurent Castillo, Margarita de la Pisa Carrión, Marie-Luce Brasier-Clain
| Motion for a resolution | Amendment |
|---|---|
| 7. Calls on the Commission to establish minimum European standards for patients’ rights, including the right to timely treatment, informed consent and non-discrimination as well as seamless cross-border access to electronic medical records through the mandatory implementation of the European Health Data Space (EHDS); | 7. Calls on the Commission and the Member States to facilitate the exercise of patients' rights enshrined in EU and national law and to ensure, where necessary for the purposes of cross-border healthcare, secure access to relevant medical data, in accordance with Regulation (EU) 2016/679 and Regulation (EU) 2025/327; |
| Motion for a resolution | Amendment |
|---|---|
| 7. Calls on the Commission to establish minimum European standards for patients’ rights, including the right to timely treatment, informed consent and non-discrimination as well as seamless cross-border access to electronic medical records through the mandatory implementation of the European Health Data Space (EHDS); | 7. Calls on the Commission to establish common guidelines, while fully respecting the competences of the Member States, as well as minimum European standards for patients’ rights, including the right to timely treatment, informed consent and non-discrimination as well as seamless cross-border access to electronic medical records through the implementation of the European Health Data Space (EHDS); |
| Motion for a resolution | Amendment |
|---|---|
| 7. Calls on the Commission to establish minimum European standards for patients’ rights, including the right to timely treatment, informed consent and non-discrimination as well as seamless cross-border access to electronic medical records through the mandatory implementation of the European Health Data Space (EHDS); | 7. Calls on the Commission to propose minimum European standards for patients’ rights, including timely access to care, informed consent and non-discrimination; calls on the Commission and the Member States to ensure the timely and effective implementation of the EHDS Regulation, enabling patients to access their electronic health data securely and seamlessly at national and cross-border level; |
| Motion for a resolution | Amendment |
|---|---|
| 7. Calls on the Commission to establish minimum European standards for patients’ rights, including the right to timely treatment, informed consent and non-discrimination as well as seamless cross-border access to electronic medical records through the mandatory implementation of the European Health Data Space (EHDS); | 7. Stresses that patients receiving cross-border healthcare must benefit from transparent information, informed consent, non-discrimination and effective means of redress; recalls, however, that the definition of healthcare entitlements, treatment priorities and applicable standards of care remains the responsibility of the Member States in accordance with Article 168(7) TFEU; |
| Motion for a resolution | Amendment |
|---|---|
| 7. Calls on the Commission to establish minimum European standards for patients’ rights, including the right to timely treatment, informed consent and non-discrimination as well as seamless cross-border access to electronic medical records through the mandatory implementation of the European Health Data Space (EHDS); | 7. Calls on the Commission to establish minimum common European standards for patients’ rights, including the right to timely treatment, informed consent and non-discrimination as well as seamless , secure and interoperable cross-border access to electronic health records through the mandatory implementation of the European Health Data Space (EHDS); |
| Motion for a resolution | Amendment |
|---|---|
| 7. Calls on the Commission to establish minimum European standards for patients’ rights, including the right to timely treatment, informed consent and non-discrimination as well as seamless cross-border access to electronic medical records through the mandatory implementation of the European Health Data Space (EHDS); | 7. Calls on the Commission to establish minimum European standards for patients’ rights, including the right to timely treatment, informed consent, confidentiality and non-discrimination as well as seamless cross-border access to electronic medical records through the mandatory implementation of the European Health Data Space (EHDS); |
| Motion for a resolution | Amendment |
|---|---|
| 7. Calls on the Commission to establish minimum European standards for patients’ rights, including the right to timely treatment, informed consent and non-discrimination as well as seamless cross-border access to electronic medical records through the mandatory implementation of the European Health Data Space (EHDS); | 7. Calls on the Commission to establish minimum European standards for patients’ rights, including the right to timely treatment, informed consent and non-discrimination as well as seamless cross-border and intra-border access to electronic health records through the mandatory implementation of the European Health Data Space (EHDS); |
| Motion for a resolution | Amendment |
|---|---|
| 7a. Notes that telemedicine has significant potential to expand access to cross-border healthcare, in particular for patients in remote or underserved areas, persons with reduced mobility, and patients with rare or complex diseases who rely on virtual case discussion through the European Reference Networks; regrets that cross-border telemedicine remains fragmented and legally uncertain; recalls the judgment of the Court of Justice of 17 September 2025 in Case C-115/24, confirming that Directive 2005/36/EC does not apply to the virtual mobility of healthcare professionals; calls on the Commission to establish a clear Union framework defining the scope of cross-border telemedicine services and clarifying the applicable rules on recognition of professional qualifications, liability and data protection, so that telemedicine expands patients' options without ever restricting their right to choose in-person care and the general principle of the principle of immediacy in the provision of healthcare services when structuring the healthcare systems; |
| Motion for a resolution | Amendment |
|---|---|
| 7a. Calls on the Commission to establish a clinical review mechanism for prior authorisation decisions, making use of the virtual consultation panels of the European Reference Networks convened through the Clinical Patient Management System, under which a patient may require that an opinion be sought from the panel of the relevant Network when authorisation is refused, or a referral declined, on the ground that adequate healthcare is available in the Member State of affiliation; stresses that this right must be exercisable by the patient directly and must not be conditional on the support of the practitioner whose assessment is in question; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak
| Motion for a resolution | Amendment |
|---|---|
| 7a. Stresses that patients are not always aware of possible cross-border treatment options or the existence of a more suitable treatment; therefore, calls on the Commission and Member States to establish a right to second opinion, including by setting up a reimbursement system for patients choosing to exercise this right; |
| Motion for a resolution | Amendment |
|---|---|
| 7a. Calls on the Commission to establish EU maximum timelines for prior authorisation and reimbursement decisions; |
| Motion for a resolution | Amendment |
|---|---|
| 7b. Stresses that a right to cross-border healthcare which does not extend to the medicinal products of which that healthcare consists is incomplete; calls on the Commission to establish that, for the purposes of Article 8(6)(d) of Directive 2011/24/EU, healthcare is not to be regarded as available in the Member State of affiliation where a medicinal product necessary to it holds no marketing authorisation there or is not in practice obtainable, and that a Member State may not refuse authorisation on the ground that adequate care is available domestically while failing to make available the medicinal product that such care requires; calls on Member States, where treatment initiated in another Member State cannot be continued in the Member State of affiliation because the medicinal product is not marketed there, to secure supply, including by means of Article 126a of Directive 2001/83/EC, or to fund the continuation of treatment in the Member State of treatment; and calls on the Commission to ensure coherence between the present revision and the reform of the pharmaceutical legislation, noting that access conditionality mechanisms which operate by withdrawal of marketing protection afford no remedy in respect of products for which no application has ever been made in the Member State concerned; |
| Motion for a resolution | Amendment |
|---|---|
| 7b. Urges the establishment of an enhanced system of monitoring for the operation of the Cross-Border Healthcare Directive, including regular publishing of information on its levels of use and for which therapeutic areas; |
| Motion for a resolution | Amendment |
|---|---|
| 8. Calls on Member States to implement mechanisms for a direct financial compensation between competent institutions across borders, applying the payment models used under the Social Security Coordination Regulations (Regulation (EC) No 883/2004) to pay treatments covered by Directive 2011/24/EU, in order to avoid that patients are forced to forfeit the broader freedoms of this Directive to circumvent upfront costs; | 8. Calls on Member States to implement mechanisms for a direct financial compensation between competent institutions across borders, applying the payment models used under the Social Security Coordination Regulations (Regulation (EC) No 883/2004) to pay treatments covered by Directive 2011/24/EU, in order to avoid that patients are forced to forfeit the broader freedoms of this Directive to circumvent upfront costs; stresses that patients must not be required to advance or bear costs covered by their Member State of affiliation and that, for high-cost, multi-session or long-term treatment, direct settlement must be confirmed before treatment begins and a single financial guarantee must cover the entire authorised course; |
| Motion for a resolution | Amendment |
|---|---|
| 8. Calls on Member States to implement mechanisms for a direct financial compensation between competent institutions across borders, applying the payment models used under the Social Security Coordination Regulations (Regulation (EC) No 883/2004) to pay treatments covered by Directive 2011/24/EU, in order to avoid that patients are forced to forfeit the broader freedoms of this Directive to circumvent upfront costs; | 8. Calls on Member States to implement mechanisms for a direct financial compensation between competent institutions across borders, applying the payment models used under the Social Security Coordination Regulations (Regulation (EC) No 883/2004) to pay treatments covered by Directive 2011/24/EU, in order to avoid that patients are forced to forfeit the broader freedoms of this Directive to circumvent upfront costs; calls for patients to be protected, wherever practicable, from having to advance substantial medical, pharmaceutical or therapeutic costs and for direct billing or other appropriate direct-payment mechanisms to be established between competent institutions; |
Valérie Deloge, Aleksandar Nikolic, Laurent Castillo, Margarita de la Pisa Carrión, Marie-Luce Brasier-Clain
| Motion for a resolution | Amendment |
|---|---|
| 8. Calls on Member States to implement mechanisms for a direct financial compensation between competent institutions across borders, applying the payment models used under the Social Security Coordination Regulations (Regulation (EC) No 883/2004) to pay treatments covered by Directive 2011/24/EU, in order to avoid that patients are forced to forfeit the broader freedoms of this Directive to circumvent upfront costs; | 8. Stresses that Member States must remain free to decide whether to use mechanisms for direct financial compensation between competent institutions; takes the view that a blanket ban on the upfront payment of costs should not be imposed at Union level; |
| Motion for a resolution | Amendment |
|---|---|
| 8. Calls on Member States to implement mechanisms for a direct financial compensation between competent institutions across borders, applying the payment models used under the Social Security Coordination Regulations (Regulation (EC) No 883/2004) to pay treatments covered by Directive 2011/24/EU, in order to avoid that patients are forced to forfeit the broader freedoms of this Directive to circumvent upfront costs; | 8. Calls on Member States to implement mechanisms for a direct financial compensation between competent institutions across borders, applying the payment models used under the Social Security Coordination Regulations (Regulation (EC) No 883/2004) to pay treatments covered by Directive 2011/24/EU, in order to avoid that patients are forced to forfeit the broader freedoms of this Directive to circumvent upfront costs and to ensure, where such mechanisms are used, clear allocation of financial responsibilities and predictable payment procedures and timelines; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak
| Motion for a resolution | Amendment |
|---|---|
| 8. Calls on Member States to implement mechanisms for a direct financial compensation between competent institutions across borders, applying the payment models used under the Social Security Coordination Regulations (Regulation (EC) No 883/2004) to pay treatments covered by Directive 2011/24/EU, in order to avoid that patients are forced to forfeit the broader freedoms of this Directive to circumvent upfront costs; | 8. Stresses that existing upfront payment obligations remain a big hurdle for patients to access necessary cross-border healthcare; therefore, calls on Member States to implement mechanisms for a direct financial compensation between competent institutions across borders, applying the payment models used under the Social Security Coordination Regulations (Regulation (EC) No 883/2004) to pay treatments covered by Directive 2011/24/EU, in order to avoid that patients are forced to forfeit the broader freedoms of this Directive to circumvent upfront costs; |
| Motion for a resolution | Amendment |
|---|---|
| 8. Calls on Member States to implement mechanisms for a direct financial compensation between competent institutions across borders, applying the payment models used under the Social Security Coordination Regulations (Regulation (EC) No 883/2004) to pay treatments covered by Directive 2011/24/EU, in order to avoid that patients are forced to forfeit the broader freedoms of this Directive to circumvent upfront costs; | 8. Calls on Member States to implement mechanisms for a direct financial compensation between competent institutions across borders, applying the payment models used under the Social Security Coordination Regulations (Regulation (EC) No 883/2004) to pay treatments covered by Directive 2011/24/EU, in order to avoid that patients are forced to forfeit the broader freedoms of this Directive to circumvent upfront costs, while eliminating administrative barriers, fragmentation and unclarities in the application of the legislative instruments; |
| Motion for a resolution | Amendment |
|---|---|
| 8. Calls on Member States to implement mechanisms for a direct financial compensation between competent institutions across borders, applying the payment models used under the Social Security Coordination Regulations (Regulation (EC) No 883/2004) to pay treatments covered by Directive 2011/24/EU, in order to avoid that patients are forced to forfeit the broader freedoms of this Directive to circumvent upfront costs; | 8. Calls on Member States to implement mechanisms for a direct financial compensation and interoperable reimbursement frameworks between competent institutions across borders, applying the payment models used under the Social Security Coordination Regulations (Regulation (EC) No 883/2004) to pay treatments covered by Directive 2011/24/EU, in order to avoid that patients are forced to forfeit the broader freedoms of this Directive to circumvent upfront costs; |
| Motion for a resolution | Amendment |
|---|---|
| 8. Calls on Member States to implement mechanisms for a direct financial compensation between competent institutions across borders, applying the payment models used under the Social Security Coordination Regulations (Regulation (EC) No 883/2004) to pay treatments covered by Directive 2011/24/EU, in order to avoid that patients are forced to forfeit the broader freedoms of this Directive to circumvent upfront costs; | 8. Calls on Member States to implement mechanisms for a direct financial compensation between competent institutions across borders, applying the payment models used under the Social Security Coordination Regulations (Regulation (EC) No 883/2004) to pay treatments covered by Directive 2011/24/EU, in order to prevent patients from being discouraged from exercising their rights due to upfront payment requirements and financial barriers; |
| Motion for a resolution | Amendment |
|---|---|
| 8. Calls on Member States to implement mechanisms for a direct financial compensation between competent institutions across borders, applying the payment models used under the Social Security Coordination Regulations (Regulation (EC) No 883/2004) to pay treatments covered by Directive 2011/24/EU, in order to avoid that patients are forced to forfeit the broader freedoms of this Directive to circumvent upfront costs; | 8. Member States shall ensure that those mechanisms apply to authorised or otherwise reimbursable cross-border healthcare and shall provide transparent rules on invoicing, verification, currency conversion, settlement deadlines and the resolution of disputes between competent institutions, without delaying treatment or transferring financial disputes to the patient; |
| Motion for a resolution | Amendment |
|---|---|
| 8. Calls on Member States to implement mechanisms for a direct financial compensation between competent institutions across borders, applying the payment models used under the Social Security Coordination Regulations (Regulation (EC) No 883/2004) to pay treatments covered by Directive 2011/24/EU, in order to avoid that patients are forced to forfeit the broader freedoms of this Directive to circumvent upfront costs; | 8. Calls on Member States to implement mechanisms for a direct financial compensation between competent institutions across borders, applying the payment models used under the Social Security Coordination Regulations (Regulation (EC) No 883/2004) to pay treatments covered by Directive 2011/24/EU, on the condition those treatments were provided in Reference Centres of the ERN; |
| Motion for a resolution | Amendment |
|---|---|
| 8a. Member States shall ensure that rare disease patients authorised to receive treatment in another Member State are not required to make upfront payment for the costs covered by their home institution. Member States shall introduce appropriate facilitation mechanisms including, at minimum: direct institutional payment to the treating centre; soft-loan or advance payment schemes for patients without access to such direct payment arrangements; and expedited reimbursement procedures for low-income patients. Reimbursement shall cover the actual cost of the intervention and the required diagnostic tests in the Member State of treatment, as well as follow-up care provided by the local care team in coordination with the Expert Centre that has performed the intervention and shall not be capped at the tariff of the home Member State where no equivalent treatment is available at home. Non-clinical expenses such as travel, accommodation, and interpretation shall be included in the reimbursement calculation; |
| Motion for a resolution | Amendment |
|---|---|
| 8a. Calls on competent authorities in the Member States to provide patients with clear information in advance on the level of reimbursement to which they are entitled and on any additional costs they may incur; |
| Motion for a resolution | Amendment |
|---|---|
| 8b. Stresses that the requirement for upfront payment acts as a significant financial barrier and an administrative burden, effectively restricting access to cross-border healthcare and exacerbating health inequalities across the Union; |
| Motion for a resolution | Amendment |
|---|---|
| 8c. Calls for the expansion of voluntary systems of prior notification to provide patients with a written estimate of reimbursable amounts; |
| Motion for a resolution | Amendment |
|---|---|
| 8d. Urges the establishment of an enhanced system of monitoring for the operation of the Cross-Border Healthcare Directive, including regular publishing of information on its levels of use and for which therapeutic areas; |
Valérie Deloge, Aleksandar Nikolic, Laurent Castillo, Margarita de la Pisa Carrión, Marie-Luce Brasier-Clain
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to propose targeted amendments to Article 7(4) of Directive 2011/24/EU to simplify and streamline the administrative procedures for patients claiming other related costs, such as travel and accommodation expenses, based on income eligibility; stresses, in this regard, the need to establish clear and fast-track mechanisms for the reimbursement of additional costs, ensuring procedures do not impose disproportionate administrative burdens; | deleted |
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to propose targeted amendments to Article 7(4) of Directive 2011/24/EU to simplify and streamline the administrative procedures for patients claiming other related costs, such as travel and accommodation expenses, based on income eligibility; stresses, in this regard, the need to establish clear and fast-track mechanisms for the reimbursement of additional costs, ensuring procedures do not impose disproportionate administrative burdens; | 9. Calls on the Commission to propose targeted amendments to Article 7(4) of Directive 2011/24/EU to simplify and streamline the administrative procedures for patients claiming other related costs, such as travel and accommodation expenses, based on income eligibility; stresses that, for patients whose Member State of affiliation has no land border and for patients resident in island regions, travel is not an ancillary cost but a precondition of access to cross-border healthcare, and calls for the cost of travel for the patient and for a companion whose presence is clinically necessary to be treated as an integral component of the authorised healthcare rather than as a related cost subject to separate claim; in this regard, the need to establish clear and fast-track mechanisms for the reimbursement of additional costs, ensuring procedures do not impose disproportionate administrative burdens; |
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to propose targeted amendments to Article 7(4) of Directive 2011/24/EU to simplify and streamline the administrative procedures for patients claiming other related costs, such as travel and accommodation expenses, based on income eligibility; stresses, in this regard, the need to establish clear and fast-track mechanisms for the reimbursement of additional costs, ensuring procedures do not impose disproportionate administrative burdens; | 9. Calls on the Commission to propose targeted amendments to Article 7(4) of Directive 2011/24/EU to simplify and streamline the administrative procedures for patients claiming other related costs, such as travel and accommodation expenses, and, where necessary, the costs of an accompanying person, with particular regard to persons with disabilities and patients with rare, ultra-rare or complex diseases, based on income eligibility and taking into account financial vulnerability and medical and support needs; stresses, in this regard, the need to establish clear and fast-track mechanisms for the reimbursement of additional costs, ensuring procedures do not impose disproportionate administrative burdens or discourage patients from seeking cross-border treatment for lack of financial means; |
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to propose targeted amendments to Article 7(4) of Directive 2011/24/EU to simplify and streamline the administrative procedures for patients claiming other related costs, such as travel and accommodation expenses, based on income eligibility; stresses, in this regard, the need to establish clear and fast-track mechanisms for the reimbursement of additional costs, ensuring procedures do not impose disproportionate administrative burdens; | 9. Calls on the Commission to propose targeted amendments to Article 7(4) of Directive 2011/24/EU to simplify and streamline the administrative procedures for patients claiming other related costs, such as travel and accommodation expenses, based on income eligibility; stresses, in this regard, the need to establish clear and fast-track mechanisms for the reimbursement of additional costs, ensuring procedures do not impose disproportionate administrative burdens; stresses the need to ensure that such costs do not constitute an obstacle to accessing necessary cross-border healthcare, especially for patients requiring highly specialised care or treatment far from their place of residence; |
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to propose targeted amendments to Article 7(4) of Directive 2011/24/EU to simplify and streamline the administrative procedures for patients claiming other related costs, such as travel and accommodation expenses, based on income eligibility; stresses, in this regard, the need to establish clear and fast-track mechanisms for the reimbursement of additional costs, ensuring procedures do not impose disproportionate administrative burdens; | 9. Calls on the Commission to propose targeted amendments to Article 7(4) of Directive 2011/24/EU to simplify and streamline the administrative procedures for patients claiming other related costs, such as travel and accommodation expenses, based on income eligibility and geographic remoteness, with special consideration for the logistical and financial hurdles faced by residents of outermost, mountain, and island regions; stresses, in this regard, the need to establish clear and fast-track mechanisms for the reimbursement of additional costs, ensuring procedures do not impose disproportionate administrative burdens; |
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to propose targeted amendments to Article 7(4) of Directive 2011/24/EU to simplify and streamline the administrative procedures for patients claiming other related costs, such as travel and accommodation expenses, based on income eligibility; stresses, in this regard, the need to establish clear and fast-track mechanisms for the reimbursement of additional costs, ensuring procedures do not impose disproportionate administrative burdens; | 9. Considers that Member States may, in accordance with national law, provide support for necessary travel and accommodation costs in duly justified cases, particularly where the treatment is medically necessary and not available within a time limit which is medically justifiable, taking account of the patient’s state of health and the probable course of the condition; stresses that this Directive should not establish a general Union entitlement to the reimbursement of ancillary costs; |
| Motion for a resolution | Amendment |
|---|---|
| 9a. Calls on the Commission to propose targeted amendments to Article 7(4) of Directive 2011/24/EU to simplify and streamline the administrative procedures for patients claiming other related costs, such as travel and accommodation expenses, based on income eligibility; stresses, in this regard, the need to establish clear and fast-track mechanisms for the reimbursement of additional costs, ensuring procedures do not impose disproportionate administrative burdens; underlines that, for patients with ultra-rare diseases whose only available expertise is concentrated in a small number of centres across the Union, cross-border care is not a matter of choice but of necessity, and that prior authorisation must not be refused on cost grounds alone where no equivalent treatment is available in the Member State of affiliation; considers that the concentration of highly specialised expertise must never, in itself, become a financial barrier to access; |
| Motion for a resolution | Amendment |
|---|---|
| 9a. Calls on the Commission and the Member States to build dedicated accommodation capacity close to healthcare providers for patients receiving cross-border care and their accompanying family members or carers, making full use of relevant Union funding instruments; stresses that such accommodation should be accessible to all eligible patients and available free of charge or at an affordable cost for the duration of treatment and medically necessary follow-up; calls on Member States to ensure that necessary accommodation costs linked to authorised cross-border healthcare can be reimbursed or directly settled, including where dedicated patient accommodation is not available, so that patients are not required to pre-finance such costs; |
| Motion for a resolution | Amendment |
|---|---|
| 9a. Stresses that patients living in island, mountain and remote regions and regions with low population density face additional geographical and economic barriers in terms of accessing specialised healthcare; calls on the Commission and Member States to ensure that particular consideration is given to the specific circumstances of these regions when implementing cross-border healthcare, particularly in relation to the prior approval and cover of necessary travel and accommodation expenses, including the cost of transportation from the place of residence to the place of departure towards the Member State of treatment; |
| Motion for a resolution | Amendment |
|---|---|
| 9a. Calls on Member States to publish the reference tariffs, or where no tariff schedule exists the costing methodology, by which reimbursement under Article 7(4) is calculated, and to ensure that the written estimate provided under Article 9(5) binds the competent institution save where the clinical circumstances materially change; stresses that in Member States whose systems are financed by general taxation and free at the point of use, no reference tariff is published, with the result that patients cannot establish before travelling what proportion of the cost they will bear; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| 9a. Calls on the Commission to set up an EU level solidarity mechanism to help vulnerable patients overcome financial barriers, particularly for patients with rare or complex diseases, patients with limited financial means, children or patients with frequent care needs. Such mechanism should provide targeted financial support, including through covering upfront payments or additional costs incurred when accessing cross-border healthcare, thus ensuring that financial circumstances do not prevent patients from accessing necessary healthcare in another Member State; |
| Motion for a resolution | Amendment |
|---|---|
| 9a. Calls for Member States to ensure that vulnerable patients, including children, persons with disabilities, and patients with rare or complex diseases, are entitled, where necessary for accessing cross-border healthcare, to appropriate financial support covering reasonable and necessary travel and accommodation costs, and that, where the patient requires the presence of a parent, guardian or caregiver, the same entitlement to reasonable and necessary travel and accommodation costs shall apply to the accompanying person; |
| Motion for a resolution | Amendment |
|---|---|
| 9a. Calls on the Commission to propose an EU funding mechanism to support cross-border access to innovative treatments, including advanced therapy medicinal products (ATMPs) and orphan medicines, where the patient’s Member State lacks a treatment centre capable of providing the required care; |
| Motion for a resolution | Amendment |
|---|---|
| 9a. Calls for the strategic mobilisation of Union financing instruments under the next Multiannual Financial Framework to build healthcare capacity, reduce health inequalities between regions, and ensure that cross-border healthcare operates on the fundamental value of European solidarity; |
| Motion for a resolution | Amendment |
|---|---|
| 9b. Calls on the Commission to propose a European Health Solidarity Mechanism for cross-border care, financed through a dedicated Union budgetary envelope and national contributions, to cover the gap between the amount payable by the Member State of affiliation and the applicable public or contracted tariff in the Member State of treatment when medically necessary care cannot be provided in the Member State of affiliation within a medically justifiable time limit; stresses that the mechanism must complement national obligations, apply transparent criteria based on medical need and treatment capacity and pay the competent institution or healthcare provider directly, so that the uncovered cost does not fall on the patient; |
| Motion for a resolution | Amendment |
|---|---|
| 9b. Notes with concern that, in practice, patients face complex, inaccessible or unclear routes to seek redress in cross-border disputes and are often redirected between national authorities without clear guidance on where responsibility lies; calls on the Commission to establish common minimum Union requirements for accessible, transparent and effective cross-border complaint and redress procedures, including clear information provided by National Contact Points, defined response times, multilingual support and clear escalation pathways for unresolved disputes, building on and strengthening existing Union problem-solving mechanisms; |
| Motion for a resolution | Amendment |
|---|---|
| 9b. Calls on the Commission to propose proportionate maximum periods for decisions on prior authorisation and reimbursement, with shorter periods where clinically necessary; requires competent institutions to acknowledge complete applications promptly, identify missing information without delay and provide written reasons where a decision period is not met, while ensuring access to an effective administrative or judicial review; |
| Motion for a resolution | Amendment |
|---|---|
| 9b. Calls on the European Commission, in cooperation with Member States and without prejudice to national competences for pricing, reimbursement and healthcare financing, to facilitate the exchange of best practices and, where appropriate, develop guidance to support the implementation of innovative reimbursement arrangements in cross-border treatment pathways; |
| Motion for a resolution | Amendment |
|---|---|
| 9b. Stresses the need for special care to be taken to ensure that residents of border regions at the Union's external borders have adequate and timely access to healthcare within the Union, limiting their reliance on healthcare services outside of the Union; |
| Motion for a resolution | Amendment |
|---|---|
| 9b. Calls for reimbursement procedures to avoid unnecessary certified or sworn translations of medical documentation and invoices, unless objectively justified and proportionate; |
| Motion for a resolution | Amendment |
|---|---|
| 10. Encourages the reinforcement and sustainable financing of ERNs as central engines of cross-border clinical cooperation; urges the Commission, in this regard, to propose a framework granting ERNs a distinct legal status to enable them to directly apply for EU funding, sign contracts, and effectively working as unified entities within national health systems; | 10. Encourages the reinforcement and sustainable financing of ERNs as central engines of cross-border clinical cooperation; urges the Commission, in this regard, to propose a framework granting ERNs a distinct legal status to enable them to directly apply for EU funding, sign contracts, and effectively working as unified entities within national health systems; calls on the Commission and Member States to provide dedicated, multi-annual infrastructure funding to structurally integrate and finance dedicated clinical Case Managers directly within ERN reference sites to coordinate patient mobility and clinical pathways in direct liaison with national navigation services; |
Valérie Deloge, Aleksandar Nikolic, Laurent Castillo, Margarita de la Pisa Carrión, Marie-Luce Brasier-Clain
| Motion for a resolution | Amendment |
|---|---|
| 10. Encourages the reinforcement and sustainable financing of ERNs as central engines of cross-border clinical cooperation; urges the Commission, in this regard, to propose a framework granting ERNs a distinct legal status to enable them to directly apply for EU funding, sign contracts, and effectively working as unified entities within national health systems; | 10. Encourages voluntary cooperation between Member States and centres of expertise within European reference networks, particularly in the field of rare diseases, whilst fully respecting the organisation and funding of national health systems; |
| Motion for a resolution | Amendment |
|---|---|
| 10. Encourages the reinforcement and sustainable financing of ERNs as central engines of cross-border clinical cooperation; urges the Commission, in this regard, to propose a framework granting ERNs a distinct legal status to enable them to directly apply for EU funding, sign contracts, and effectively working as unified entities within national health systems; | 10. Encourages the reinforcement and sustainable financing of ERNs as central engines of cross-border clinical cooperation; urges the Commission, in this regard, to propose a framework that supports the involvement of the ERNs in cross-border and multinational research activities, including clinical trials, real-world evidence generation, data sharing and the development of clinical pathways and guidelines; |
| Motion for a resolution | Amendment |
|---|---|
| 10. Encourages the reinforcement and sustainable financing of ERNs as central engines of cross-border clinical cooperation; urges the Commission, in this regard, to propose a framework granting ERNs a distinct legal status to enable them to directly apply for EU funding, sign contracts, and effectively working as unified entities within national health systems; | 10. Encourages the reinforcement and sustainable financing of ERNs as central engines of cross-border clinical cooperation, knowledge-sharing and access to specialised expertise; urges the Commission, in this regard, to propose a framework granting ERNs a distinct legal status to enable them to directly apply for EU funding, sign contracts, and effectively working as integrated networks supporting national healthcare systems; |
| Motion for a resolution | Amendment |
|---|---|
| 10. Encourages the reinforcement and sustainable financing of ERNs as central engines of cross-border clinical cooperation; urges the Commission, in this regard, to propose a framework granting ERNs a distinct legal status to enable them to directly apply for EU funding, sign contracts, and effectively working as unified entities within national health systems; | 10. Encourages the reinforcement and sustainable financing of ERNs as central engines of cross-border clinical cooperation especially in emerging areas such as women's health; urges the Commission, in this regard, to propose a framework granting ERNs a distinct legal status to enable them to directly apply for EU funding, sign contracts, and effectively working as unified entities within national health systems; |
| Motion for a resolution | Amendment |
|---|---|
| 10. Encourages the reinforcement and sustainable financing of ERNs as central engines of cross-border clinical cooperation; urges the Commission, in this regard, to propose a framework granting ERNs a distinct legal status to enable them to directly apply for EU funding, sign contracts, and effectively working as unified entities within national health systems; | 10. Calls for the sustainable financing of ERNs as central engines of cross-border clinical cooperation; urges the Commission, in this regard, to propose a framework granting ERNs a distinct legal status to enable them to directly apply for EU funding, sign contracts, and effectively working as unified entities within national health systems; |
| Motion for a resolution | Amendment |
|---|---|
| 10a. Encourages the reinforcement and sustainable financing of ERNs as central engines of cross-border clinical cooperation; urges the Commission, in this regard, to propose a framework granting ERNs a distinct legal personality to enable them to directly apply for EU funding, sign contracts, and effectively work as unified entities within national health systems, with protected expert time for participating professionals and clear accountability for their care, training, data and research functions; calls for stable financing to be secured jointly at Union and national level, building on the work of the JARDIN Joint Action, and for full geographical coverage of all 24 ERNs to be achieved in every Member State, noting that only 14 Member States currently benefit from complete coverage; underlines that this reinforcement must be pursued in full coherence with the recommendations of the Committee's parallel own-initiative report on an EU Rare Disease Action Plan (2025/2130(INL); |
| Motion for a resolution | Amendment |
|---|---|
| 10a. Particular attention shall be paid to ensuring the sustainable financing of the European Reference Networks and their better integration into national healthcare systems, with a view to enhancing their contribution to research, diagnosis, treatment and continuity of care, particularly for patients living with rare diseases or rare cancers; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| 10a. Underlines that the effectiveness of European Reference Networks depends on adequate and predictable funding, including remuneration for the healthcare professionals involved in virtual case discussions through the Clinical Patient Management System, and on a regular and transparent schedule for the expansion of the Networks; |
| Motion for a resolution | Amendment |
|---|---|
| 10a. Stresses the need to strengthen cross-border coordination and cross-border accessibility, by ensuring stable and predictable financing for ERN, including dedicated reimbursement mechanisms for healthcare professionals participating in virtual consultation panels via the Clinical Patient Management System (CPMS); |
| Motion for a resolution | Amendment |
|---|---|
| 10a. Underlines the need to maximise the added value of ERNs by ensuring that they have adequate resources and an appropriate mandate to provide advice, support and guidance to patients seeking specialised healthcare in a Member State other than their Member State of affiliation; |
| Motion for a resolution | Amendment |
|---|---|
| 10a. Calls on the Commission and Member States to ensure the structural integration of ERNs into national healthcare systems and to establish clear and accessible referral pathways for patients to benefit from the expertise available within the networks; |
| Motion for a resolution | Amendment |
|---|---|
| 10b. Urges the Commission to establish a more frequent and predictable cycle for ERN expansion calls, replacing ad-hoc procedures with a transparent, regular schedule; recalls that there has not been a new expansion call since 2019; emphasises that a clearly defined timeline is essential for the timely integration of national centres of excellence, thereby bridging the gap between local expertise and Union-wide collaboration to ensure rare disease patients receive specialised care and that medical insights are shared without administrative delays; |
| Motion for a resolution | Amendment |
|---|---|
| 10b. The Commission shall promote closer cooperation between the European Reference Networks, research infrastructures, patient organisations and relevant Union initiatives in order to translate the research results into more accurate diagnosis, treatment and care for patients; |
| Motion for a resolution | Amendment |
|---|---|
| 10b. Stresses that, for patients with rare and complex diseases, cross-border access to specialised expertise is oftentimes critical to their health, safety and survival, and should therefore be treated as an essential component of care rather than an exceptional measure; |
| Motion for a resolution | Amendment |
|---|---|
| 10c. Calls for appropriate reimbursement mechanisms for healthcare professionals participating in cross-border virtual consultations and multidisciplinary expert panels, including through the Clinical Patient Management System; |
| Motion for a resolution | Amendment |
|---|---|
| 10c. Emphasises that digitalisation in healthcare must serve the public interest and must not exclude elderly persons, persons with disabilities or digitally disadvantaged populations, in full alignment with the European Declaration on Digital Rights and Principles for the Digital Decade and the inclusion principles of the European Health Data Space; |
| Motion for a resolution | Amendment |
|---|---|
| 11. Stresses that robust, patient-centric mechanisms for the secure exchange of health-related data and best practices across Union health systems must be prioritised within the regulatory framework, including through the mandatory expansion of the MyHealth@EU infrastructure, to ensure that patients moving between Member States receive high-standard healthcare; | 11. Stresses that robust, patient-centric mechanisms for the secure exchange of personal electronic health data and, clinical information and best practices across Union health systems must be prioritised within the regulatory framework, including through the mandatory expansion of the MyHealth@EU infrastructure and the European electronic health record exchange format; stresses that such interoperable mechanisms for healthcare services, including telemedicine should enable patients moving between Member States to benefit from timely access to relevant health information, continuity of care and high-standard healthcare, including through the seamless exchange of patient summaries, ePrescriptions, eDispensations, medical imaging, medical test results and discharge reports, as well as additional categories of personal electronic health data provided for under national law; |
| Motion for a resolution | Amendment |
|---|---|
| 11. Stresses that robust, patient-centric mechanisms for the secure exchange of health-related data and best practices across Union health systems must be prioritised within the regulatory framework, including through the mandatory expansion of the MyHealth@EU infrastructure, to ensure that patients moving between Member States receive high-standard healthcare; | 11. Stresses that robust, patient-centric mechanisms for the secure exchange of personal electronic health data and best practices across Union health systems must be prioritised within the regulatory framework, including through the mandatory expansion of the MyHealth@EU infrastructure and the European Health Data Space (EHDS); stresses the need for interoperable cross-border healthcare services, including telemedicine, to ensure that patients can access high-quality care irrespective of the Member State in which the healthcare professional is located; stresses that the deployment of digital tools, including telemedicine, must preserve patients’ direct access to healthcare professionals and their proximity to quality healthcare infrastructure, including community pharmacies, as well as protect patient choice and ensure non-digital access; |
| Motion for a resolution | Amendment |
|---|---|
| 11. Stresses that robust, patient-centric mechanisms for the secure exchange of health-related data and best practices across Union health systems must be prioritised within the regulatory framework, including through the mandatory expansion of the MyHealth@EU infrastructure, to ensure that patients moving between Member States receive high-standard healthcare; | 11. Stresses that the regulatory framework should prioritise robust, patient-centred mechanisms for the secure exchange of health data and best practices across Union health systems; emphasises that the cross-border healthcare framework should build on the interoperability requirements established under Regulation (EU) 2025/327, in line with its implementation timelines, while avoiding parallel or duplicative data-exchange requirements, in order to ensure that patients receiving healthcare in another Member State benefit from high-quality care; |
| Motion for a resolution | Amendment |
|---|---|
| 11. Stresses that robust, patient-centric mechanisms for the secure exchange of health-related data and best practices across Union health systems must be prioritised within the regulatory framework, including through the mandatory expansion of the MyHealth@EU infrastructure, to ensure that patients moving between Member States receive high-standard healthcare; | 11. Stresses that any cross-border exchange of health data must comply fully with applicable data-protection rules, the principles of data minimisation and purpose limitation and, where applicable, the patient’s explicit choice; considers that patients must not be denied or disadvantaged in accessing healthcare solely because they do not use a digital service; |
| Motion for a resolution | Amendment |
|---|---|
| 11. Stresses that robust, patient-centric mechanisms for the secure exchange of health-related data and best practices across Union health systems must be prioritised within the regulatory framework, including through the mandatory expansion of the MyHealth@EU infrastructure, to ensure that patients moving between Member States receive high-standard healthcare; | 11. Stresses that robust, patient-centric mechanisms for the secure exchange of health-related data and best practices across Union health systems must be prioritised within the regulatory framework, including through the mandatory expansion of the MyHealth@EU infrastructure, to ensure that patients moving between Member States receive high-standard healthcare; insists, however, that the digital transition must be fully inclusive and accompanied by non-digital alternatives; |
| Motion for a resolution | Amendment |
|---|---|
| 11. Stresses that robust, patient-centric mechanisms for the secure exchange of health-related data and best practices across Union health systems must be prioritised within the regulatory framework, including through the mandatory expansion of the MyHealth@EU infrastructure, to ensure that patients moving between Member States receive high-standard healthcare; | 11. Stresses that robust, patient-centric mechanisms for the secure exchange of health-related data and best practices across Union health systems must be prioritised within the regulatory framework, including through the mandatory expansion of the MyHealth@EU infrastructure, and supporting interoperable mechanisms for healthcare services, including telemedicine, to ensure that patients moving between Member States receive high-standard healthcare; |
| Motion for a resolution | Amendment |
|---|---|
| 11. Stresses that robust, patient-centric mechanisms for the secure exchange of health-related data and best practices across Union health systems must be prioritised within the regulatory framework, including through the mandatory expansion of the MyHealth@EU infrastructure, to ensure that patients moving between Member States receive high-standard healthcare; | 11. Stresses that robust, interoperable, patient-centric mechanisms for the secure exchange of health-related data and best practices across Union health systems must be prioritised within the regulatory framework, including through the mandatory expansion of the MyHealth@EU infrastructure, to ensure that patients moving between Member States receive high-standard healthcare; |
| Motion for a resolution | Amendment |
|---|---|
| 11a. Calls for an EU-wide interoperable electronic health record system under strict public oversight and full compliance with data protection rules; Encourages secure and interoperable cross-border data sharing using the European electronic health record exchange format to facilitate translation into the official languages of the Union for clinical and research purposes, while ensuring full compliance with Union data protection and privacy rules, in particular Regulation(EU) 2025/327 and Regulation (EU) 2016/679; stresses the importance of robust governance frameworks, high standards of data security, and the use of privacy-preserving technologies, including pseudonymisation and anonymisation, to safeguard patients’ rights; underlines the need to ensure transparency regarding the framework managing patients’ data, and the provision of easily accessible opt-out mechanisms, in order to strengthen patients´ trust in the use of their health data, thus facilitating the secondary use of health data for research and innovation, notably in the field of rare diseases; |
| Motion for a resolution | Amendment |
|---|---|
| 11a. Community pharmacies constitute an indispensable public-health infrastructure that ensures the safe, continuous and equitable supply of medicinal products and professional advice to the population, in particular in rural, insular, mountainous and low-density areas. Their professionally-led establishment, based on demographic and geographic planning criteria, has created a capillary network that prevents the emergence of “pharmacy deserts” and vertebrates local communities. This network constitutes a value for the healthcare system in itself, in addition to and distinct from its function as a channel for the distribution of medicines, and it is not to be regarded as a mere commercial activity subject to market logic. Nothing in this Directive, or in measures adopted to implement it, shall be interpreted as weakening the professional, territorially-planned nature of this model; |
| Motion for a resolution | Amendment |
|---|---|
| 11a. Stresses that the increasing use of digital health services and the need for access to specialised healthcare across Member States require a clear and patient-centred framework for cross-border telemedicine; recognises the potential of telemedicine to improve timely and equitable access to healthcare, including specialised expertise and second opinions, reduce unnecessary travel and associated costs and facilitate continuity of care, particularly for patients living in remote or underserved areas and those requiring regular follow-up; calls for cross-border telemedicine to be fully recognised within the cross-border healthcare framework and governed by clear and enforceable rules on reimbursement, professional responsibility and liability, applicable standards of care and coordination with the patient’s domestic healthcare system; |
| Motion for a resolution | Amendment |
|---|---|
| 11a. Calls on the Commission, in cooperation with the Member States and without requiring the identification of patients, to assess the impact on public health of complications arising from planned treatment received in third countries, including the need for follow-up care or corrective treatment upon patients’ return to the Union; takes the view that comparable and aggregated data are necessary to identify risks to patient safety, improve preventive and information policies and assess the effects on the organisational capacity and financial sustainability of national healthcare systems; |
| Motion for a resolution | Amendment |
|---|---|
| 11a. Stresses that rare disease research requires critical mass in patient recruitment, data pooling and biobank coordination, which can only be achieved through structured cross-border collaboration and strategic alignment of Union funding instruments. Therefore it encourages the integration of rare disease registries and data infrastructures within the European Health Data Space in a manner that ensures interoperability, cybersecurity and full compliance with Union data protection legislation, through the use of standardised coding systems such as the ORPHAcodes maintained by Orphanet; |
| Motion for a resolution | Amendment |
|---|---|
| 11a. Notes that digital health services, including telemedicine, can contribute significantly to improving continuity of care, reducing administrative burdens and facilitating patients’ access to healthcare; stresses that their safe and effective deployment, while fully respecting patients’ fundamental rights, including the rights to privacy and the protection of personal data, should be supported by interoperable European digital health solutions and frameworks, including the European Health Data Space, MyHealth@EU and the EU Digital Identity Wallet; |
| Motion for a resolution | Amendment |
|---|---|
| 11a. Calls on the Commission to establish a single Union digital platform for cross-border healthcare, connected to National Contact Points and MyHealth@EU, enabling patients to identify suitable healthcare providers, specialised centres, relevant expert and patient support networks , compare available treatment pathways, prior-authorisation conditions and expected reimbursement, submit and track their requests and receive confirmation of coverage before treatment; |
Valérie Deloge, Aleksandar Nikolic, Laurent Castillo, Margarita de la Pisa Carrión, Marie-Luce Brasier-Clain
| Motion for a resolution | Amendment |
|---|---|
| 11a. Stresses that any cross-border exchange of health data must be limited to the data necessary for patient care, and must be secure and compliant with Regulation (EU) 2016/679, Regulation (EU) 2025/327 and the applicable national rules on medical confidentiality; stresses that interoperability must ensure continuity of care without giving rise to the centralisation of medical records at EU level; |
| Motion for a resolution | Amendment |
|---|---|
| 11a. Calls on the Commission to provide greater legal clarity regarding cross-border telemedicine, including healthcare professional-to-patient and healthcare professional-to-healthcare professional consultations provided for the benefit of an individual patient, as well as care pathways combining remote and in-person healthcare, while respecting Member States’ competence for the organisation and delivery of healthcare; |
Liesbet Sommen, Pascal Arimont, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| 11a. Calls on Member States to implement Regulation (EU) 2025/327 on the European Health Data Space in a timely, uniform and interoperable manner; calls on the Commission to closely monitor the state of implementation across Member States and to report regularly to Parliament on progress made and on any divergences liable to undermine the cross-border healthcare potential of the European Health Data Space; |
| Motion for a resolution | Amendment |
|---|---|
| 11a. Stresses that Member States should ensure that cross-border telemedicine is accessible under conditions equivalent to comparable in-person healthcare, while maintaining appropriate standards of patient safety, professional responsibility, data protection and reimbursement; |
| Motion for a resolution | Amendment |
|---|---|
| 11a. Stresses the special role telemedicine plays in ensuring equal access to specialised healthcare services for all; |
| Motion for a resolution | Amendment |
|---|---|
| 11b. Considers that the purpose of digital tools deployed under this Directive and under Regulation (EU) 2025/327 establishing the European Health Data Space must be to make it easier for citizens who travel or reside temporarily in another Member State to identify, reach and be served by a local, physical pharmacy and healthcare professional, in particular through interoperable electronic prescriptions and patient summary exchange via MyHealth@EU; underlines that this objective of travel ease is distinct from, and shall not be conflated with, the creation of new rights or expectations of cross-border distance sale or home delivery of medicinal products; recalls that an estimated 46 % of the approximately 7.8 million cross-border prescriptions presented for dispensation each year in the Union are currently not dispensed, mainly owing to interoperability, translation and information gaps, and considers that closing that gap through wider and better-supported MyHealth@EU connectivity for existing local pharmacies must be the priority, rather than developing parallel cross-border distance-supply channels that would bypass local pharmacy networks; |
| Motion for a resolution | Amendment |
|---|---|
| 11b. Telemedicine, including digital or technological services provided by pharmacies, is becoming increasingly important in ensuring continuity of care in a cross-border setting, particularly for patients with chronic conditions requiring regular medication and for those living in remote or underserved areas. Through digital technologies, telemedicine enables the remote provision of healthcare services for the diagnosis, treatment and prevention of diseases and injuries, including remote monitoring, teleconsultations, electronic prescribing and the dispensing of medicinal products and medical devices. It can also improve the provision of healthcare by supporting research and strengthening the continuous education, training and professional support of the healthcare workforce; |
Liesbet Sommen, Pascal Arimont, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| 11b. Stresses that the implementation of the European Health Data Space and the deployment of digital tools, including telemedicine, should enable patients to exercise their rights regardless of their Member State of affiliation. Interoperable clinical information has the potential to increase patients’ access to high-quality cross-border healthcare and to improve the continuity of care. For the purpose of this Directive, telemedicine should encompass both patient-to-healthcare provider and healthcare provider-to-healthcare provider interactions. Calls on the Commission to update the legislative framework for reimbursement accordingly; |
| Motion for a resolution | Amendment |
|---|---|
| 11b. Stresses that digital health infrastructure and the exchange of electronic health data should enable, but cannot substitute for, appropriate clinical assessment, professional accountability, quality and safety standards and continuity of care; calls for patients receiving cross-border telemedicine to have access to their relevant health information and to clear information on the identity and place of establishment of the healthcare provider, applicable rules, patients’ rights and avenues for redress, as well as appropriate follow-up and timely referral to in-person care where clinically necessary; |
| Motion for a resolution | Amendment |
|---|---|
| 11b. Emphasises that digital health services, including telemedicine, can reduce administrative burdens and facilitate access to healthcare in rural, remote and underserved areas and should therefore be supported by interoperable European digital infrastructure, including MyHealth@EU, the European Health Data Space and, where appropriate, the EU Digital Identity Wallet; |
| Motion for a resolution | Amendment |
|---|---|
| 11c. Stresses that community pharmacies fulfil a service of general economic interest within the meaning of Article 106(2) TFEU, combining the supply of medicines with professional advice, therapeutic follow-up, promotion of the rational use of medicines, and early detection of adverse interactions or poor adherence, and that they act as a stable healthcare reference point, in particular for elderly, chronically ill or isolated patients in rural areas; recalls that this added value was clearly demonstrated during the COVID-19 pandemic, when community pharmacies remained among the few healthcare services to stay continuously open, guaranteeing access to medicines, reliable health information and professional guidance; considers that this function cannot be replicated by purely logistical or platform-based distance-supply models, and calls for this Directive to be implemented in a manner that reinforces, rather than substitutes, the proximity-based pharmacy model, facilitating access to them and the interoperability of reimbursement schemes for European citizens travelling or temporarely residing in another country within the territory of the Union; |
| Motion for a resolution | Amendment |
|---|---|
| 11c. Stresses that any development of telepharmacy and cross-border online medicine supply mechanisms must be designed to improve patients’ equitable access to safe and appropriate medicines, including in border, rural and underserved areas, while preserving continuity of care, appropriate professional supervision and the role and responsibility of qualified healthcare professionals; stresses that such developments must not lead to a market-driven concentration of medicine supply in the most profitable areas or exacerbate inequalities affecting rural populations, older people or people facing digital exclusion; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak
| Motion for a resolution | Amendment |
|---|---|
| 11c. Highlights that the deployment of digital tools should be seen as a means to access healthcare which cannot fully replace direct access to healthcare providers, non-digital access or the physical supply of medical or medicinal products. The deployment of digital tools should enhance access to high-quality cross-border healthcare where necessary without jeopardising the independence of healthcare professionals; |
| Motion for a resolution | Amendment |
|---|---|
| 11c. Stresses that digitalisation must complement, rather than replace, human support and that patients who cannot access or use digital services must retain equivalent access to information and support through non-digital means; |
| Motion for a resolution | Amendment |
|---|---|
| 11d. Stresses that rare diseases must be explicitly recognised as a priority use case within the European Health Data Space, including through a dedicated data module, the systematic use of ORPHAcodes, harmonised minimum datasets and federated analysis models that enable cross-border research without unnecessary centralisation of sensitive data; calls on Member States to designate and adequately resource national health data access bodies capable of efficiently handling cross-border rare disease data requests; underlines that, absent such measures, the European Health Data Space risks delivering a data infrastructure that systematically under-represents the estimated 27 to 36 million people living with a rare disease in the Union; |
| Motion for a resolution | Amendment |
|---|---|
| 11d. Recalls that Directive 2005/36/EC concerns the recognition of professional qualifications and does not harmonise the conditions governing the exercise of healthcare professions or the organisation of pharmacy services; stresses that remote or hybrid working arrangements must not prevent effective professional supervision, obscure the identity and place of establishment of the responsible professional or pharmacy, or be used to circumvent national requirements adopted for patient safety and public health; considers that any future assessment of such working arrangements should be conducted in the appropriate legislative framework and give priority to patient safety, professional accountability and effective enforcement; |
| Motion for a resolution | Amendment |
|---|---|
| 11d. Calls on Member States to ensure that physical health insurance cards, including national cards with the European Health Insurance Card (EHIC) on the reverse side, remain accessible while enabling their integration into mobile phone wallets to simplify cross-border verification and quick healthcare access; |
| Motion for a resolution | Amendment |
|---|---|
| 11b. Calls on the Commission and Member States to take specific action to ensure the inclusion of the most underserved patient groups. In particular, by adopting accessibility standards for all cross-border healthcare administrative processes—including prior authorisation applications, reimbursement claims, and ensuring all NCP websites strictly comply with W3C Web Content Accessibility Guidelines, ensuring compliance with the European Accessibility Act and the UN CRPD; |
| Motion for a resolution | Amendment |
|---|---|
| 12. Stresses the need for multiannual, renewable cross-border care authorisations for patients with chronic, long-term or progressively deteriorating health conditions who require ongoing treatment, replacing the current practice of requiring repeated individual authorisations for each treatment episode, which places an unacceptable administrative burden on the most vulnerable patients; | 12. Stresses the need for multiannual, renewable cross-border care authorisations for patients with chronic, long-term or progressively deteriorating health conditions who require ongoing treatment, replacing the current practice of requiring repeated individual authorisations for each treatment episode, which places an unacceptable administrative burden on the most vulnerable patients; underlines the importance of ensuring continuity of care, legal certainty and predictable access to treatment, while allowing for periodic review where clinically justified; |
| Motion for a resolution | Amendment |
|---|---|
| 12. Stresses the need for multiannual, renewable cross-border care authorisations for patients with chronic, long-term or progressively deteriorating health conditions who require ongoing treatment, replacing the current practice of requiring repeated individual authorisations for each treatment episode, which places an unacceptable administrative burden on the most vulnerable patients; | 12. Stresses the need for multiannual, renewable cross-border care authorisations for patients with chronic, long-term, rare, complex, or progressively deteriorating health conditions who require ongoing treatment, replacing the current practice of requiring repeated individual authorisations for each treatment episode, which creates dangerous clinical delays and places an unacceptable administrative burden on the most vulnerable patients and their treating physicians; |
| Motion for a resolution | Amendment |
|---|---|
| 12a. Calls on the Commission and the Member States to facilitate continuity of therapy, including for haemodialysis and peritoneal dialysis, for patients travelling temporarily to another Member State for work, education, family reasons or holidays; calls, in particular, for clear and patient-friendly procedures enabling advance booking at appropriately authorised dialysis centres, the secure exchange of the relevant clinical information, and direct settlement between competent institutions where applicable; |
| Motion for a resolution | Amendment |
|---|---|
| 13. Calls on the Commission and Member States to formally recognise in the revised legislative framework that rare and complex diseases require, by their very nature, highly specialised expertise, multi-disciplinary care coordination, and access to cutting-edge research and innovation that cannot be equitably or consistently delivered within national borders alone; and to formally recognise that, accordingly, access to cross-border healthcare for patients with rare and complex diseases must be treated not as an exception but as a structural feature of the Union's healthcare system, deserving of dedicated legal provisions, guaranteed funding, and proactive facilitation by Member States; | 13. Calls on the Commission and Member States to adopt special provisions for patients with chronic, rare or complex diseases that require continuous or specialised cross-border care, including multi-year renewable authorisations, appropriate funding and simplified access procedures; |
| Motion for a resolution | Amendment |
|---|---|
| 13. Calls on the Commission and Member States to formally recognise in the revised legislative framework that rare and complex diseases require, by their very nature, highly specialised expertise, multi-disciplinary care coordination, and access to cutting-edge research and innovation that cannot be equitably or consistently delivered within national borders alone; and to formally recognise that, accordingly, access to cross-border healthcare for patients with rare and complex diseases must be treated not as an exception but as a structural feature of the Union's healthcare system, deserving of dedicated legal provisions, guaranteed funding, and proactive facilitation by Member States; | 13. Calls on the Commission and Member States to formally recognise in the revised legislative framework that rare and complex diseases require, by their very nature, highly specialised expertise, multi-disciplinary care coordination, and access to cutting-edge treatment and research and innovation, that cannot be equitably or consistently delivered within national borders alone; and to formally recognise that, accordingly, access to cross-border healthcare for patients with rare and complex diseases must be treated not as an exception but as a structural feature of the Union's healthcare system, deserving of dedicated legal provisions, guaranteed funding, and proactive facilitation by Member States; identifies that more than one clinically appropriate specialised provider might be available and calls on Member States, wherever possible, to enable patients to make an informed choice between providers, taking account of quality, continuity of care, reasonable travel considerations and available capacity; calls in this regard for the establishment of a European Agency for Rare Diseases to enable the best cross-border treatment, research and coordination; |
Valérie Deloge, Aleksandar Nikolic, Laurent Castillo, Margarita de la Pisa Carrión, Marie-Luce Brasier-Clain
| Motion for a resolution | Amendment |
|---|---|
| 13. Calls on the Commission and Member States to formally recognise in the revised legislative framework that rare and complex diseases require, by their very nature, highly specialised expertise, multi-disciplinary care coordination, and access to cutting-edge research and innovation that cannot be equitably or consistently delivered within national borders alone; and to formally recognise that, accordingly, access to cross-border healthcare for patients with rare and complex diseases must be treated not as an exception but as a structural feature of the Union's healthcare system, deserving of dedicated legal provisions, guaranteed funding, and proactive facilitation by Member States; | 13. Emphasises that rare diseases may require highly specialised expertise which is not available in all Member States; calls on Member States to facilitate access to cross-border healthcare where the appropriate diagnosis or treatment is not available in the Member State of affiliation or cannot be provided there within a medically justifiable timeframe, provided that the care in question falls within the scope of the benefits to which the patient is entitled in that Member State; |
| Motion for a resolution | Amendment |
|---|---|
| 13. Calls on the Commission and Member States to formally recognise in the revised legislative framework that rare and complex diseases require, by their very nature, highly specialised expertise, multi-disciplinary care coordination, and access to cutting-edge research and innovation that cannot be equitably or consistently delivered within national borders alone; and to formally recognise that, accordingly, access to cross-border healthcare for patients with rare and complex diseases must be treated not as an exception but as a structural feature of the Union's healthcare system, deserving of dedicated legal provisions, guaranteed funding, and proactive facilitation by Member States; | 13. Calls on the Commission and Member States to formally recognise in the revised legislative framework that rare and complex diseases require, by their very nature, highly specialised expertise, multi-disciplinary care coordination, and access to cutting-edge research and innovation that cannot be equitably or consistently delivered within national borders alone; and to formally recognise that, accordingly, access to cross-border healthcare for patients with rare and complex diseases must be treated not as an exception but as a structural feature of the Union's healthcare system, deserving of dedicated legal provisions, guaranteed funding, and proactive facilitation by Member States; calls on the Member States with sub-optimal domestic treatment capacity, lower health expenditure, or documented survival rate disparities, to establish systematic, proactive outbound cross-border patient referral pathways to certified European Reference Centres immediately upon diagnosis; |
| Motion for a resolution | Amendment |
|---|---|
| 13. Calls on the Commission and Member States to formally recognise in the revised legislative framework that rare and complex diseases require, by their very nature, highly specialised expertise, multi-disciplinary care coordination, and access to cutting-edge research and innovation that cannot be equitably or consistently delivered within national borders alone; and to formally recognise that, accordingly, access to cross-border healthcare for patients with rare and complex diseases must be treated not as an exception but as a structural feature of the Union's healthcare system, deserving of dedicated legal provisions, guaranteed funding, and proactive facilitation by Member States; | 13. Calls on the Commission and Member States to formally recognise in the revised legislative framework that rare and complex diseases require, by their very nature, highly specialised expertise, multi-disciplinary care coordination, and access to cutting-edge research and innovation that cannot be equitably or consistently delivered within national borders alone; and to formally recognise that, accordingly, access to cross-border healthcare for patients with rare and complex diseases must be treated not as an exception but as a structural feature of the Union's healthcare system, deserving of dedicated legal provisions, including a dedicated cross-border care pathway covering diagnosis, referral, multidisciplinary assessment, access to authorised innovative medicinal products and advanced therapies, and follow-up and continuity of care, guaranteed funding, and proactive facilitation by Member States; |
| Motion for a resolution | Amendment |
|---|---|
| 13. Calls on the Commission and Member States to formally recognise in the revised legislative framework that rare and complex diseases require, by their very nature, highly specialised expertise, multi-disciplinary care coordination, and access to cutting-edge research and innovation that cannot be equitably or consistently delivered within national borders alone; and to formally recognise that, accordingly, access to cross-border healthcare for patients with rare and complex diseases must be treated not as an exception but as a structural feature of the Union's healthcare system, deserving of dedicated legal provisions, guaranteed funding, and proactive facilitation by Member States; | 13. Calls on the Commission and Member States to formally recognise in the revised legislative framework that rare and complex diseases require, by their very nature, highly specialised expertise, multi-disciplinary care coordination, and access to cutting-edge research and innovation that cannot be equitably or consistently delivered within national borders alone; and to formally recognise that, accordingly, access to cross-border healthcare for patients with rare and complex diseases must be treated not as an exception but as a structural feature of the Union's healthcare system, deserving of dedicated legal provisions, guaranteed funding, and proactive facilitation by Member States; stresses, in this regard, the urgent need to structurally integrate European Reference Networks (ERNs) into national healthcare systems and referral pathways, building on the ongoing work of the JARDIN Joint Action; |
| Motion for a resolution | Amendment |
|---|---|
| 13. Calls on the Commission and Member States to formally recognise in the revised legislative framework that rare and complex diseases require, by their very nature, highly specialised expertise, multi-disciplinary care coordination, and access to cutting-edge research and innovation that cannot be equitably or consistently delivered within national borders alone; and to formally recognise that, accordingly, access to cross-border healthcare for patients with rare and complex diseases must be treated not as an exception but as a structural feature of the Union's healthcare system, deserving of dedicated legal provisions, guaranteed funding, and proactive facilitation by Member States; | 13. Calls on the Commission and Member States to formally recognise in the revised legislative framework that rare and complex diseases require, by their very nature, highly specialised expertise, multi-disciplinary care coordination, and access to cutting-edge research and innovation that cannot be equitably or consistently delivered within national borders alone; and to formally recognise that, accordingly, access to cross-border healthcare for patients with rare and complex diseases must be treated not as an exception but as a structural feature of the Union's healthcare system, deserving of dedicated legal provisions, guaranteed funding, and proactive facilitation by Member States, irrespective of patients’ place of residence or socioeconomic status; |
| Motion for a resolution | Amendment |
|---|---|
| 13. Calls on the Commission and Member States to formally recognise in the revised legislative framework that rare and complex diseases require, by their very nature, highly specialised expertise, multi-disciplinary care coordination, and access to cutting-edge research and innovation that cannot be equitably or consistently delivered within national borders alone; and to formally recognise that, accordingly, access to cross-border healthcare for patients with rare and complex diseases must be treated not as an exception but as a structural feature of the Union's healthcare system, deserving of dedicated legal provisions, guaranteed funding, and proactive facilitation by Member States; | 13. Calls on the Commission and Member States to formally recognise in the revised legislative framework that rare and complex diseases require, by their very nature, highly specialised expertise, multi-disciplinary care coordination, and access to cutting-edge research and innovation that cannot be equitably or consistently provided within national borders alone; and to formally recognise that, accordingly, access to cross-border healthcare for patients with rare and complex diseases must be treated not as an exception but as a structural feature of the Union's healthcare system, deserving of dedicated legal provisions, guaranteed funding, and proactive facilitation by Member States; |
| Motion for a resolution | Amendment |
|---|---|
| 13a. Stresses that the Union's global leadership in health research and innovation is a strategic comparative advantage; underlines the need to preserve Europe's competitive edge in advanced scientific specialisation, addressing the loss of talent, particularly to the United States, and ensuring that Europe's scientific excellence tangibly benefits our patients; |
| Motion for a resolution | Amendment |
|---|---|
| 14. Calls on the Commission to extend the scope of EU cross-border healthcare legislation to explicitly cover participation in clinical trials for rare and complex diseases, including early-phase trials, recognising that, for conditions in which low-intervention trials form part of standard treatment and experimental therapies offer a second chance to patients with relapsed or refractory malignancies, access to research conducted in selected centres across Europe is an essential, rather than optional, component of care. | deleted |
| Motion for a resolution | Amendment |
|---|---|
| 14. Calls on the Commission to extend the scope of EU cross-border healthcare legislation to explicitly cover participation in clinical trials for rare and complex diseases, including early-phase trials, recognising that, for conditions in which low-intervention trials form part of standard treatment and experimental therapies offer a second chance to patients with relapsed or refractory malignancies, access to research conducted in selected centres across Europe is an essential, rather than optional, component of care. | 14. Calls on the Commission to extend the scope of EU cross-border healthcare legislation to explicitly cover participation in clinical trials for rare and complex diseases, including early-phase trials, recognising that, for conditions in which low-intervention trials form part of standard treatment and experimental therapies offer a second chance to patients with relapsed or refractory malignancies, access to research conducted in selected centres across Europe is an essential, rather than optional, component of care; stresses that this should also cover paediatric trials and that participation in a clinical trial in another Member State must not exclude reimbursement of otherwise eligible cross-border healthcare and medically necessary travel and accommodation costs; recalls that costs to be provided free of charge to subjects under Article 92 of Regulation (EU) No 536/2014 must not be charged to patients; |
| Motion for a resolution | Amendment |
|---|---|
| 14. Calls on the Commission to extend the scope of EU cross-border healthcare legislation to explicitly cover participation in clinical trials for rare and complex diseases, including early-phase trials, recognising that, for conditions in which low-intervention trials form part of standard treatment and experimental therapies offer a second chance to patients with relapsed or refractory malignancies, access to research conducted in selected centres across Europe is an essential, rather than optional, component of care. | 14. Calls on the Commission to extend the scope of EU cross-border healthcare legislation to explicitly cover participation in clinical trials for rare and complex diseases, including early-phase trials, recognising that, for conditions in which low-intervention trials form part of standard treatment and experimental therapies offer a second chance to patients with relapsed or refractory malignancies, access to research conducted in selected centres across Europe is an essential, rather than optional, component of care. calls further for the creation of a structured cross-border exchange framework for advanced therapy medicinal products (ATMPs) under the hospital exemption scheme, ensuring patients with ultra-rare conditions can access cutting-edge treatments even if they are clinically unable to travel; |
| Motion for a resolution | Amendment |
|---|---|
| 14. Calls on the Commission to extend the scope of EU cross-border healthcare legislation to explicitly cover participation in clinical trials for rare and complex diseases, including early-phase trials, recognising that, for conditions in which low-intervention trials form part of standard treatment and experimental therapies offer a second chance to patients with relapsed or refractory malignancies, access to research conducted in selected centres across Europe is an essential, rather than optional, component of care. | 14. Calls on the Commission to extend the scope of EU cross-border healthcare legislation to explicitly cover participation in clinical trials for rare and complex diseases, including early-phase trials, recognising that, for conditions in which low-intervention trials form part of standard treatment and experimental therapies offer a second chance to patients with relapsed or refractory malignancies, access to research conducted in selected centres across Europe is an essential, rather than optional, component of care; calls for appropriate support mechanisms to address financial, administrative and logistical barriers preventing patients from participating in such trials, while ensuring coherence with the EU Clinical Trials Regulation and the development of personalised medicine approaches; |
| Motion for a resolution | Amendment |
|---|---|
| 14. Calls on the Commission to extend the scope of EU cross-border healthcare legislation to explicitly cover participation in clinical trials for rare and complex diseases, including early-phase trials, recognising that, for conditions in which low-intervention trials form part of standard treatment and experimental therapies offer a second chance to patients with relapsed or refractory malignancies, access to research conducted in selected centres across Europe is an essential, rather than optional, component of care. | 14. Calls on the Commission to extend the scope of EU cross-border healthcare legislation to explicitly cover participation in clinical trials for rare and complex diseases, including early-phase trials, recognising that, for conditions in which low-intervention trials form part of standard treatment and experimental therapies offer a second chance to patients with relapsed or refractory malignancies, access to research conducted in selected centres across Europe is an essential, rather than optional, component of care; calls on the Commission to establish that these research-based interventions are eligible for S2 pre-authorisation and reimbursement when standard curative treatments have failed; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak
| Motion for a resolution | Amendment |
|---|---|
| 14. Calls on the Commission to extend the scope of EU cross-border healthcare legislation to explicitly cover participation in clinical trials for rare and complex diseases, including early-phase trials, recognising that, for conditions in which low-intervention trials form part of standard treatment and experimental therapies offer a second chance to patients with relapsed or refractory malignancies, access to research conducted in selected centres across Europe is an essential, rather than optional, component of care. | 14. Calls on the Commission to extend the scope of EU cross-border healthcare legislation to explicitly cover participation in clinical trials for rare and complex diseases, including early-phase trials, distinguishing between research participation and trials recognised as treatment pathway, recognising that, for conditions in which low-intervention trials form part of standard treatment and experimental therapies offer a second chance to patients with relapsed or refractory malignancies, access to research conducted in selected centres across Europe is an essential, rather than optional, component of care. |
| Motion for a resolution | Amendment |
|---|---|
| Mental health and complex psychiatric care | |
| 14a. Stresses that severe, complex and treatment-resistant mental disorders — including severe and enduring eating disorders, complex neuropsychiatric conditions, highly specialised child and adolescent inpatient care and secure forensic psychiatric care — require specialised services which the smaller Member States cannot sustainably maintain, and that such care must be expressly within the scope of the revised framework and of the multiannual, renewable authorisations referred to in paragraph 12;14b. Calls on the Commission to publish guidelines for the cross-border placement of patients who lack capacity to consent or who are subject to involuntary treatment or detention under national mental health legislation, addressing the lawful basis for treatment and detention in the Member State of treatment, the cross-border recognition of consent and of substitute decision-making, the authority responsible for reviewing the placement, and arrangements for the patient’s return, in accordance with the UN Convention on the Rights of Persons with Disabilities; |
| Motion for a resolution | Amendment |
|---|---|
| 14a. Calls on the Commission to take into account the measures set out in the proposed European Biotech Act aimed at facilitating the development of advanced therapy medicinal products for rare diseases, in particular by supporting more efficient cross-border clinical trials for small and geographically dispersed patient populations, promoting combined studies involving medicinal products, devices or diagnostics, and centres of excellence for advanced therapies, with a view to accelerating innovation while maintaining high standards of patient safety, data quality and regulatory oversight. |
| Motion for a resolution | Amendment |
|---|---|
| 14a. Stresses the need to ensure that patients with rare diseases are not denied life-saving treatments solely because the medicine concerned is not reimbursed in their Member State of affiliation; calls, therefore, on the Commission to propose a targeted amendment to Article 7(1) of Directive 2011/24/EU to create a specific derogation for rare and complex diseases, requiring Member States to establish emergency reimbursement procedures for cross-border treatments and orphan medicines even if they are not yet included in the patient's national basket of benefits; |
| Motion for a resolution | Amendment |
|---|---|
| 14a. Calls on the Commission to assess practical barriers to cross-border participation, including the interaction between the cross-border healthcare and clinical trials frameworks and the respective responsibilities for healthcare, travel, accommodation and follow-up costs, and to identify whether targeted Union measures may be needed; |
| Motion for a resolution | Amendment |
|---|---|
| 14a. Calls on the Commission and Member States to ensure that cross-border healthcare cooperation also supports prevention, early detection and health promotion, particularly in areas where European cooperation can improve access to screening programmes, specialised diagnostics and evidence-based preventive interventions; |
| Motion for a resolution | Amendment |
|---|---|
| 14a. Calls on National Contact Points to provide patients with accessible and regularly updated information on specialised centres, European Reference Networks, available cross-border treatment pathways, relevant clinical trials and innovative therapies, where appropriate; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| 14a. Calls on the Commission and Member States to establish simplified administrative procedures related to cross-border clinical trials participation and reimbursement, especially for rare diseases and paediatric cancers. |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak
| Motion for a resolution | Amendment |
|---|---|
| 14b. Stresses that the current legal framework allows for Member States to set up systems to make patients, health professionals and bodies responsible for the funding of healthcare aware of the possibilities offered by Regulation 883/2004 for patients to access healthcare which is not available in the Member State of affiliation; calls on the Commission to assess the adequacy of this system and, if necessary, to propose strengthening this system by establishing in the Directive the possibility for reimbursement procedures on a case-by-case basis for cross-border healthcare which is not reimbursed in the Member State of affiliation; |
| Motion for a resolution | Amendment |
|---|---|
| Gender equality and women’s health |
| Motion for a resolution | Amendment |
|---|---|
| 14b. Calls on the Commission and Member States to address gender inequalities in access to cross-border healthcare and to ensure that women and girls can benefit from timely and equitable access to specialised healthcare services, including for reproductive health, maternal care, endometriosis, gynaecological cancers and other conditions disproportionately affecting women; stresses the importance of integrating a gender-sensitive approach throughout the implementation and evaluation of the cross-border healthcare framework; |
| Motion for a resolution | Amendment |
|---|---|
| Special Protection and Prioritisation for Children | Special Protection and Prioritisation for Children paediatric, rare and complex conditions |
| Motion for a resolution | Amendment |
|---|---|
| 15. Calls on the Commission and Member States to establish child-specific provisions within the cross-border healthcare framework guaranteeing priority access to paediatric specialist care and, expedited authorisation procedures, and amending Article 7(4) of Directive 2011/24/EU to ensure the mandatory reimbursement of travel and accommodation costs for both the child and their accompanying parents or guardians, in recognition of children's particular vulnerability and the inseparability of family support from effective paediatric care; | 15. Calls on the Commission and Member States to establish child-specific provisions within the cross-border healthcare framework guaranteeing priority access to paediatric specialist care and, expedited authorisation procedures, and amending Article 7(4) of Directive 2011/24/EU to ensure the mandatory reimbursement of travel and accommodation costs for both the child and their accompanying parents or guardians, in recognition of children's particular vulnerability and the inseparability of family support from effective paediatric care; stresses that a single authorisation decision and financial guarantee must cover the minor patient and at least one accompanying parent or legal guardian throughout the entire authorised course of treatment, including medically necessary follow-up care and repeat journeys, without requiring a separate application for each treatment episode; |
| Motion for a resolution | Amendment |
|---|---|
| 15. Calls on the Commission and Member States to establish child-specific provisions within the cross-border healthcare framework guaranteeing priority access to paediatric specialist care and, expedited authorisation procedures, and amending Article 7(4) of Directive 2011/24/EU to ensure the mandatory reimbursement of travel and accommodation costs for both the child and their accompanying parents or guardians, in recognition of children's particular vulnerability and the inseparability of family support from effective paediatric care; | 15. Calls on the Commission and Member States to establish child-specific provisions within the cross-border healthcare framework for people with paediatric, rare and complex diseases, based on the principle of the best interests of the child, guaranteeing priority access to paediatric specialist care and, expedited authorisation procedures, and amending Article 7(4) of Directive 2011/24/EU to ensure the mandatory reimbursement of travel and accommodation costs for both the patient and their accompanying parents, carers, in recognition of children's particular vulnerability and the inseparability of family support from effective paediatric care; |
| Motion for a resolution | Amendment |
|---|---|
| 15. Calls on the Commission and Member States to establish child-specific provisions within the cross-border healthcare framework guaranteeing priority access to paediatric specialist care and, expedited authorisation procedures, and amending Article 7(4) of Directive 2011/24/EU to ensure the mandatory reimbursement of travel and accommodation costs for both the child and their accompanying parents or guardians, in recognition of children's particular vulnerability and the inseparability of family support from effective paediatric care; | 15. Calls on the Commission and Member States to establish child-specific provisions within the cross-border healthcare framework guaranteeing priority access to paediatric specialist care and, expedited authorisation procedures, and amending Article 7(4) of Directive 2011/24/EU to ensure the mandatory reimbursement or direct coverage of travel and accommodation costs for both the child and their accompanying parents or guardians, in recognition of children's particular vulnerability and the inseparability of family or caregiver support from effective paediatric care; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| 15. Calls on the Commission and Member States to establish child-specific provisions within the cross-border healthcare framework guaranteeing priority access to paediatric specialist care and, expedited authorisation procedures, and amending Article 7(4) of Directive 2011/24/EU to ensure the mandatory reimbursement of travel and accommodation costs for both the child and their accompanying parents or guardians, in recognition of children's particular vulnerability and the inseparability of family support from effective paediatric care; | 15. Calls on the Commission and Member States to establish child-specific provisions within the cross-border healthcare framework guaranteeing priority access to paediatric specialist care and, expedited authorisation procedures, and amending Article 7(4) of Directive 2011/24/EU to ensure the mandatory reimbursement of travel and accommodation costs for both the child and their accompanying parents, guardians or designated responsible person, in recognition of children's particular vulnerability and the inseparability of family support from effective paediatric care; |
| Motion for a resolution | Amendment |
|---|---|
| 16. Calls on the Commission and Member States to recognise the specific medical, social and emotional needs of children with rare and complex diseases and to require each Member State to establish national cross-border navigator services providing personalised, cost-free guidance for young patients, their families and their caregivers throughout the entire cross-border care pathway, thereby reducing the disproportionate administrative burden placed on families navigating fragmented health systems; | 16. Calls on the Commission and Member States to recognise the specific medical, social and emotional needs of people with rare and complex diseases and to require each Member State to establish national cross-border navigator services providing personalised, cost-free guidance for young patients, their families and their caregivers throughout the entire cross-border care pathway, thereby reducing the disproportionate administrative burden placed on families navigating fragmented health systems; |
| Motion for a resolution | Amendment |
|---|---|
| 16a. Considers that the framework should reduce diagnostic delay through coordinated principles on screening of newborns, voluntary convergence of genomic testing standards and strengthened cross-border referral mechanisms, in order to promote social equality both across and within Member States and to tackle social and territorial disparities for children, specially those living with a rare disease or rare cancer due to the unavailability of early diagnosis and screening programmes; |
| Motion for a resolution | Amendment |
|---|---|
| 16a. Stresses that patient organisations should be formally recognised as partners in supporting families navigating cross-border care, including with regard to information, administrative procedures, translation and practical arrangements; |
| Motion for a resolution | Amendment |
|---|---|
| 17. Calls on the Commission and Member States to provide dedicated, multi-annual infrastructure funding to strengthen and expand existing cross-border networks in rare and complex disease areas, including the European Reference Networks established under Directive 2011/24/EU, with a view to fostering specialist capacity across the Union and reducing geographic disparities to access to expertise; | 17. Calls on the Commission and Member States to provide dedicated, sustainable and multi-annual infrastructure funding to strengthen and expand existing cross-border networks in rare and complex disease areas, including the European Reference Networks established under Directive 2011/24/EU, with a view to fostering specialist capacity across the Union, supporting multidisciplinary paediatric expertise and coordinated care pathways, and reducing geographic and socioeconomic disparities in access to expertise and high quality care; |
| Motion for a resolution | Amendment |
|---|---|
| 17. Calls on the Commission and Member States to provide dedicated, multi-annual infrastructure funding to strengthen and expand existing cross-border networks in rare and complex disease areas, including the European Reference Networks established under Directive 2011/24/EU, with a view to fostering specialist capacity across the Union and reducing geographic disparities to access to expertise; | 17. Calls on the Commission and Member States to provide dedicated, multi-annual infrastructure funding to strengthen and expand existing cross-border networks in rare and complex disease areas, including the European Reference Networks established under Directive 2011/24/EU, and to facilitate access to ATMPs, with a view to strengthening specialist capacity and reducing geographical disparities in access to expertise across the Union; |
| Motion for a resolution | Amendment |
|---|---|
| 17. Calls on the Commission and Member States to provide dedicated, multi-annual infrastructure funding to strengthen and expand existing cross-border networks in rare and complex disease areas, including the European Reference Networks established under Directive 2011/24/EU, with a view to fostering specialist capacity across the Union and reducing geographic disparities to access to expertise; | 17. Calls on the Commission and Member States to provide sufficient, dedicated, multi-annual infrastructure funding to strengthen and expand existing cross-border networks in rare and complex disease areas, including the European Reference Networks established under Directive 2011/24/EU, with a view to fostering specialist capacity across the Union and reducing geographic disparities to access to expertise; |
| Motion for a resolution | Amendment |
|---|---|
| 17a. Stresses that digital technologies can facilitate communication between patients and healthcare professionals, access to health information and continuity of care across borders; stresses, however, that the electronic transmission of a prescription and the provision of professional advice at a distance should be distinguished from the dispensing and physical supply of the medicinal product, which remain subject to the applicable Union and national rules on prescribing, dispensing, classification, substitution, pharmacy practice, safety features, distribution, distance sales and delivery, including the rules of the Member State of destination; |
| Motion for a resolution | Amendment |
|---|---|
| 17a. Digital technologies can facilitate communication between patients and healthcare professionals, access to health information and continuity of care across borders. The electronic transmission of a prescription and the provision of professional advice at a distance should, however, be distinguished from the dispensing and physical supply of the medicinal product. Those activities remain subject to the applicable Union and national rules on prescribing, dispensing, classification, substitution, pharmacy practice, safety features, distribution, distance sales and delivery, including the rules of the Member State of destination; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak
| Motion for a resolution | Amendment |
|---|---|
| Healthcare in border regions |
Liesbet Sommen, Pascal Arimont, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak
| Motion for a resolution | Amendment |
|---|---|
| 17a. Stresses that, for the approximately one third of Union citizens living in a border region, cross-border healthcare is everyday healthcare; calls on the Commission to include in the revised legislative framework a dedicated chapter on healthcare in border regions, together with a definition of border region for the purposes of that framework; |
| Motion for a resolution | Amendment |
|---|---|
| Emergency Cross-Border Healthcare and European Solidarity |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak
| Motion for a resolution | Amendment |
|---|---|
| 17b. Calls on the Commission and the Member States to give effect to the principle of the nearest appropriate healthcare provider, under which access to, and reimbursement of, healthcare in a border region are determined by medical need and by actual travel time to the provider rather than by the location of the national border; stresses that the Member State of affiliation should not be able to refuse authorisation or reimbursement on the sole ground that equivalent treatment is available on its own territory where that treatment is accessible only at a significantly greater distance or travel time; |
| Motion for a resolution | Amendment |
|---|---|
| 17b. Calls for the revised framework to provide for accelerated cross-border healthcare cooperation in situations of recognised public health emergencies or other exceptional circumstances causing acute pressure on healthcare infrastructure, including by facilitating the rapid transfer of patients, healthcare professionals, and medical supplies across borders; |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| 17c. Calls on the Commission to propose a Union framework for cross-border healthcare access zones, building on the arrangements already operating along several internal borders, under which the competent authorities of two or more neighbouring Member States may designate a defined geographical area and a defined list of healthcare providers within which residents may obtain ambulatory and hospital care on the other side of the border without prior authorisation and without advance payment; |
| Motion for a resolution | Amendment |
|---|---|
| 17c. Calls on Member States, in such circumstances, to be able to waive or substantially simplify prior authorisation requirements and apply fast-track reimbursement and direct-payment procedures where necessary to avoid delays to medically necessary treatment; |
| Motion for a resolution | Amendment |
|---|---|
| 17d. Calls on the Commission to ensure that such arrangements build on and complement existing Union mechanisms for serious cross-border threats to health and relevant experience in providing cross-border assistance during major humanitarian or health crises; |
| Motion for a resolution | Amendment |
|---|---|
| Persons with Disabilities |
| Motion for a resolution | Amendment |
|---|---|
| 17e. Calls on the Commission and Member States to ensure that persons with disabilities are not prevented from exercising their rights to cross-border healthcare because of additional costs arising from their disability, including accessible transport, accommodation, personal assistance or other reasonable support necessary to receive treatment; |
| Motion for a resolution | Amendment |
|---|---|
| 17f. Calls for all information, prior authorisation and reimbursement procedures under the Directive to be accessible to persons with disabilities, including through accessible digital formats and appropriate non-digital alternatives; |
| Motion for a resolution | Amendment |
|---|---|
| 17a. Underlines that the continuity of care must be organised and encouraged within the national and regional health systems of the European countries to make a broad collaboration in cross border healthcare possible. Quality, public healthcare services need to be available close to where patients live, in a timely manner, and in their own language. |
| Motion for a resolution | Amendment |
|---|---|
| 18. Stresses the necessity of fully implementing the European Health Data Space (EHDS), the MyHealth@EU infrastructure and the European electronic health record exchange format to ensure the seamless cross-border transfer of patient summaries and discharge reports; | deleted |
| Motion for a resolution | Amendment |
|---|---|
| 18. Stresses the necessity of fully implementing the European Health Data Space (EHDS), the MyHealth@EU infrastructure and the European electronic health record exchange format to ensure the seamless cross-border transfer of patient summaries and discharge reports; | deleted |
| Motion for a resolution | Amendment |
|---|---|
| 18. Stresses the necessity of fully implementing the European Health Data Space (EHDS), the MyHealth@EU infrastructure and the European electronic health record exchange format to ensure the seamless cross-border transfer of patient summaries and discharge reports; | 18. Stresses the necessity of fully implementing the European Health Data Space (EHDS), the expansion and interoperability of MyHealth@EU infrastructure and the European electronic health record exchange format to ensure the secure, seamless and timely cross-border access to and exchange of essential health information, including patient summaries, ePrescriptions, eDispensations, medical imaging, medical test results and discharge reports, as well as any additional categories of personal electronic health data based on national law provided for by Member States and other relevant medical data, thereby strengthening continuity of care for patients receiving healthcare across Member States; underlines the importance of ensuring patient control over their health data, high standards of data protection, cybersecurity and interoperability between national health systems and adequate follow-up care; |
| Motion for a resolution | Amendment |
|---|---|
| 18. Stresses the necessity of fully implementing the European Health Data Space (EHDS), the MyHealth@EU infrastructure and the European electronic health record exchange format to ensure the seamless cross-border transfer of patient summaries and discharge reports; | 18. Emphasises that cross-border continuity of care depends on healthcare professionals having access to clear, reliable and interoperable clinical information, in order to support safe diagnosis, treatment, follow-up care and patient safety across the Union; Stresses, in this regard, the necessity of fully implementing the European Health Data Space (EHDS), the MyHealth@EU infrastructure and the European electronic health record exchange format to ensure the seamless cross-border transfer of patient summaries and discharge reports; |
| Motion for a resolution | Amendment |
|---|---|
| 18. Stresses the necessity of fully implementing the European Health Data Space (EHDS), the MyHealth@EU infrastructure and the European electronic health record exchange format to ensure the seamless cross-border transfer of patient summaries and discharge reports; | 18. Stresses the necessity of fully implementing the European Health Data Space (EHDS), the MyHealth@EU infrastructure and the European electronic health record exchange format to ensure the seamless cross-border transfer of patient summaries and discharge reports; calls on the Member States of affiliations to legally recognize digital medical assessments and prescriptions issued by certified healthcare professionals in the Member State of treatment without requiring additional reassessments; |
| Motion for a resolution | Amendment |
|---|---|
| 18. Stresses the necessity of fully implementing the European Health Data Space (EHDS), the MyHealth@EU infrastructure and the European electronic health record exchange format to ensure the seamless cross-border transfer of patient summaries and discharge reports; | 18. Stresses the necessity of fully implementing the European Health Data Space (EHDS), the MyHealth@EU infrastructure and the European electronic health record exchange format to ensure, inter alia, the seamless cross-border transfer of patient summaries, discharge reports, ePrescriptions, eDispensations, medical imaging, medical test results; |
| Motion for a resolution | Amendment |
|---|---|
| Calls on Member States to publish annually comparable and appropriately anonymised data on requests, positive and negative decisions, decision times, patient flows, therapeutic areas and destinations for publicly funded treatment abroad, including treatment financed under bilateral arrangements with third countries; calls on the Commission to assess the scale, quality safeguards and continuity arrangements of such bilateral pathways and to report to Parliament; |
| Motion for a resolution | Amendment |
|---|---|
| 18a. Calls on the Commission, in cooperation with the Member States and without extending the scope of Directive 2011/24/EU to healthcare provided in third countries, to look into the feasibility of establishing a proportionate framework at Union level for the collection of anonymised, aggregated and comparable data on follow-up care provided within the Union for complications arising from planned healthcare services received in third countries; takes the view that, where available, such data should include the type of treatment initially provided, the nature and severity of the complication, the corrective healthcare services required, any hospital admissions and the associated costs borne by national healthcare systems; stresses that such information could help to identify the chief risk factors, improve patient information and prevention, and ascertain the clinical, organisational and financial impact on public healthcare systems, whilst ensuring compliance with EU data protection law and avoiding disproportionate administrative burdens on healthcare providers. |
Liesbet Sommen, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| 18a. Stresses the continuity of care should be ensured for every patient treated across a border in the form of the necessary follow-up care, aftercare, rehabilitation or palliative care in their Member State of affiliation, in the same manner as if they would have received the care in their own Member State; calls on the Commission to propose a revised framework to cover the entire pathway, ensuring the recognition of follow-up care needs, adequate systems to support health workforce, safe patient handover and the ongoing communication between patients and healthcare providers across borders taking into account existing language barriers; |
| Motion for a resolution | Amendment |
|---|---|
| 18a. Stresses that authorisation for cross-border healthcare should extend to the episode of care as a whole, including planned follow-up and the continuation of treatment initiated in the Member State of treatment, and calls on Member States to require competent institutions to state, at the point of authorisation, how continuity of care on return will be secured, including access to medicinal products initiated abroad which are not included in the national formulary and to any rehabilitation required by the discharging centre; |
| Motion for a resolution | Amendment |
|---|---|
| 18a. Calls on Member States to strictly enforce their obligations under Article 5(c) of Directive 2011/24/EU to ensure that patients returning to their Member State of affiliation after treatment abroad receive the exact same medical follow-up as they would have received domestically; demands further that Member States ensure that transparent liability rules and accessible complaint mechanisms are in place, and proactively communicated to patients, for instances where continuity failures or clinical errors cause harm; |
| Motion for a resolution | Amendment |
|---|---|
| 18a. Calls on the Commission to establish a European Medical Expertise Exchange Scheme financing short-term exchanges of healthcare professionals, partnerships between hospitals and medical universities, cross-border multidisciplinary teams and tele-expertise; stresses that each supported partnership should deliver joint clinical protocols, training programmes and measurable transfers of expertise to healthcare providers in Member States and regions where specialised capacity is limited or unavailable; |
| Motion for a resolution | Amendment |
|---|---|
| 18a. Stresses the need for effective systems to support health professionals and strengthen coordination between hospital and primary care services, with a view to ensuring the continuity and safety of cross-border care; calls on the Commission and the Member States, within their respective competences, to provide adequate support to the EU health workforce in order to facilitate the effective implementation of Directive 2011/24/EU; |
| Motion for a resolution | Amendment |
|---|---|
| 18a. Stresses the need to streamline diploma recognition and harmonise registration procedures across Member States to meet future demands for healthcare workers; highlights that transparent cross-border exchange of registration data and disciplinary records is essential to ensure safety and maintain high standards of care across Member States; |
| Motion for a resolution | Amendment |
|---|---|
| 18a. Stresses the importance of strengthening cross-border cooperation among healthcare professionals through training, knowledge exchange and joint capacity-building initiatives, ensuring that expertise can circulate across the Union and contribute to reducing regional disparities in healthcare capacity; |
| Motion for a resolution | Amendment |
|---|---|
| 18a. Stresses the need of safe patient handover and continuity of communication between Member States, as well as the need to define national cross-border navigators to assist patients and their families with medical, legal, administrative and financial matters associated with cross-border healthcare; |
| Motion for a resolution | Amendment |
|---|---|
| 18b. Member States shall ensure that rare disease patients authorised to receive treatment in another Member State receive appropriate, continuous, and high-quality follow-up care upon return to their Member State of affiliation. Such care shall be provided as close as practically possible to the patient's place of residence. To guarantee the safety and efficacy of the cross-border intervention, post-treatment care shall be formally organised through Shared Care Agreements established between the patient’s local clinical team and the Expert Centre that performed the intervention. These Shared Care Agreements shall be concluded prior to the patient's return and shall clearly specify: (a) the explicit division of clinical responsibilities between the Expert Centre and the local clinical team, including primary points of contact for emergency situations; (b) the detailed clinical protocols, monitoring schedules, and diagnostic tests required for the patient's ongoing surveillance; (c) the mechanism and frequency for secure data sharing, medical record synchronisation, and multi-disciplinary case reviews; (d) the protocols for the prescription, funding, and local administration of specialised orphan drugs or post-operative therapies; and (e) the financial and administrative responsibilities associated with the ongoing care, including the pathway for rapid re-referral to the Expert Centre should clinical complications arise. Member States shall facilitate the digital infrastructure and provide the necessary regulatory support to enable local clinical teams to seamlessly execute these agreements with Expert Centres across borders. |
Liesbet Sommen, Pascal Arimont, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| 18b. Calls on the Commission to include in the revised legislative framework provisions on the cooperation of emergency medical and rescue services in border regions, based on the principle that the unit dispatched must be the nearest available and appropriate unit, irrespective of the Member State in which it is stationed; calls for the revised framework to provide that unplanned and emergency healthcare received in a neighbouring Member State, including emergency medical transport by road and by air and the subsequent transfer of the patient to a healthcare provider in the Member State of affiliation once their condition permits, is covered without prior authorisation, without advance payment and without any reduction in reimbursement on the ground that the care was received abroad; |
| Motion for a resolution | Amendment |
|---|---|
| 18b. Calls on the Commission, in cooperation with the Member States concerned, to promote a EU-level pilot project focusing on planned dental treatment received in third countries, with a view to collecting anonymous and aggregated data on the prevalence of this practice, the chief complications encountered upon return to the Union, the corrective treatment required and the associated costs borne by national health systems; take the view that the pilot project should also assess the quality of commercial information provided to patients, the traceability of the devices and materials used, and the actual availability of post-treatment care and safeguards in the event of harm; |
| Motion for a resolution | Amendment |
|---|---|
| 18b. Stresses that cross-border care pathways must incorporate effective infection prevention and control and antimicrobial stewardship, supported by timely and appropriate diagnostic testing, regular review of microbiological results and evidence-based prescribing, with a view to preventing unnecessary or inappropriate antimicrobial use and ensuring effective treatment; |
| Motion for a resolution | Amendment |
|---|---|
| 18b. Highlights the importance of facilitating cross-border cooperation between healthcare professionals through mutual recognition of professional qualifications, training, expertise and specialised skills, while ensuring high standards of quality and patient safety; |
Liesbet Sommen, Pascal Arimont, Tomislav Sokol, Adam Jarubas, Sirpa Pietikäinen, Dan-Ştefan Motreanu, Radan Kanev, Dolors Montserrat, Ingeborg Ter Laak, András Tivadar Kulja
| Motion for a resolution | Amendment |
|---|---|
| 18c. Calls on Member States to ensure full interoperability between emergency control centres in border regions, including direct alerting, shared visibility of available units and common dispatch protocols; calls on the Commission to put an end to the persistent misrouting of emergency calls and location data across borders; Calls on the Commission and the Member States to remove the legal, administrative and financial obstacles that continue to hinder the cross-border deployment of emergency medical services, so as to enable emergency teams to operate seamlessly, safely and without legal uncertainty on the territory of a neighbouring Member State; |
| Motion for a resolution | Amendment |
|---|---|
| 18c. Stresses the importance of safe patient handover and the continuity of communication and information between primary and secondary care, and health and social care, within and between Member States, as well as the need to set up national cross border navigators to assist patients and their families where relevant with medical, legal, and financial matters associated with cross-border healthcare. |
| Motion for a resolution | Amendment |
|---|---|
| 18d. Stresses that in order to ensure continuous coordination and safety of care, adequate systems should be put in place to support the EU health workforce which acts as a fundamental link between the hospital sector, primary care sector and social services, establishing the bridge to enhance continuity of care and promote more dynamism within and between the health systems |
Connections
The dossier, the decisions on this text and its other versions.
No connections found for this item.
Sources & citation
Where the facts on this page come from, and how to cite it.
- Data source
- Licensed CC BY 4.0.
- Retrieved
- 25 September 2026
Cite as
European Parliament (2026). “AMENDMENTS 1 - 341 - Draft report Modernised rules for patients’ rights in cross-border healthcare”. Text, 11 September 2026. docId SANT-AM-792014. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/texts/SANT-AM-792014 (retrieved 25 September 2026). Data: EP Open Data API: document record, https://data.europarl.europa.eu/api/v2/documents/SANT-AM-792014 (CC BY 4.0).
BibTeX
@misc{epw-text-sant-am-792014,
author = {{European Parliament}},
title = {{AMENDMENTS 1 - 341 - Draft report Modernised rules for patients’ rights in cross-border healthcare}},
year = {2026},
date = {2026-09-11},
howpublished = {\url{https://news.eu-parl.st-solutions.dev/texts/SANT-AM-792014}},
url = {https://news.eu-parl.st-solutions.dev/texts/SANT-AM-792014},
urldate = {2026-09-25},
publisher = {EU Parl Watch Research},
note = {Text. docId SANT-AM-792014. Data: EP Open Data API: document record (CC BY 4.0)}
}